Approaches towards molecular amplification for sensing by Goggins, Sean & Frost, Christopher G.
        
Citation for published version:
Goggins, S & Frost, CG 2016, 'Approaches towards molecular amplification for sensing', Analyst, vol. 141, no.
11, pp. 3157-3218. https://doi.org/10.1039/c6an00348f
DOI:
10.1039/c6an00348f
Publication date:
2016
Document Version
Peer reviewed version
Link to publication
The final publication is available at the Royal Society of Chemistry via 10.1039/c6an00348f
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 13. May. 2019
Analyst  
CRITICAL REVIEW 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 1  
Please do not adjust margins 
Please do not adjust margins 
Received 00th January 20xx, 
Accepted 00th January 20xx 
DOI: 10.1039/x0xx00000x 
www.rsc.org/ 
Approaches towards Molecular Amplification for Sensing  
Sean Gogginsa* and Christopher G. Frosta 
Diagnostic assays that rely on molecular interactions have come a long way; from initial reversible detection systems towards 
irreversible reaction indicator-based methods. More recently, the emergence of innovative molecular amplification 
methodologies has revolutionised sensing, allowing diagnostic assays to achieve ultra-low limits of detection. There have 
been a significant number of molecular amplification approaches developed over recent years to accommodate the wide 
variety of analytes that require sensitive detection. To celebrate this achievement, this comprehensive critical review has 
been compiled to give a broad overview of the many different approaches used to attain amplification in sensing with an 
aim to inspire the next generation of diagnostic assays looking to achieve the ultimate detection limit. This review has been 
created with the focus on how each conceptually unique molecular amplification methodology achieves amplification, not 
just its sensitivity, while highlighting any key processes. Excluded are any references that were not found to contain an 
obvious molecular amplifier or amplification component, or that did not use an appropriate signal readout that could be 
incorporated into a sensing application. Additionally, methodologies where amplification is achieved through advances in 
instrumentation are also excluded. Depending upon the type of approach employed, amplification strategies are divided 
into four categories: target, label, signal or receptor amplification. More recent, more complex protocols combine a number 
of approaches and are therefore categorised by which amplification component described within was considered as the 
biggest advancement. The advantages and disadvantages of each methodology are discussed along with any limits of 
detection, if stated in the original article. Any subsequent use of the methodology within sensing or any other application is 
also mentioned to draw attention to its practicality. The importance of amplification within sensing is wholly emphasised 
while perspectives on the future direction of the field are also shared.
Introduction 
Amplification is the process whereby a small input signal is converted to a large output signal by means of an amplifier. Amplifiers 
are most commonly associated with electronics where they are used to increase the power of an electric signal for functions such 
as increasing audio volume. Amplifiers are also found within certain aspects of optics, fluidics and mechanics. In nature, living 
organisms use amplification for purposes such 
as visual excitation,1 blood clotting,2 and 
biosignalling.3 Typically, these amplified 
physical responses to an external stimulus are 
achieved through enzyme cascade 
mechanisms (Scheme 1).4 Specific enzyme 
cascades are initiated when a signalling 
molecule (i.e. a hormone) is detected by a 
signal receptor, which in turn activates an 
associated enzyme. Once activated, the 
enzyme can catalyse the production of 
multiple signal relay molecules, which can go 
on to activate more enzymes and so on, 
resulting in an enzyme cascade. An example of 
this can be found within the fight-or-flight 
response exhibited by animals where, in 
response to a perceived threat, epinephrine is 
a. 1 South, Department of Chemistry, University of Bath, 
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Scheme 1 Epinephrine-activated enzyme cascade for the amplified production of glucose. 
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released by the body to activate an enzyme cascade 
for increasing blood sugar levels.5 Through this 
powerful amplification mechanism, the detection of 
a single molecule of epinephrine by a receptor can 
lead to the rapid production of thousands of glucose 
molecules. Typically, amplifications over several 
orders of magnitude are observed within 
milliseconds. 
The use of amplification is also found within 
many biological and chemical sensing techniques.6 
Since a single molecule is unable to generate a strong 
enough signal to be detected, some degree of 
amplification is paramount to achieving a detection 
protocol with high sensitivity. There is huge demand 
for the ability to detect of a large variety of different 
analytes in many areas of society but particularly 
within molecular diagnostics,7 forensic analysis,8 and 
environmental monitoring.9 There is also increasing 
pressure to not only increase the sensitivity, but also 
improve the efficiency of currently existing analyte 
detection assays. As such, more and more 
amplification methodologies for a wide range of 
different analytes are constantly being developed. 
Analytes requiring detection are often structurally 
diverse in nature and the readout method chosen for 
detection also varies according to the application. To 
accommodate for this, many different amplification 
methodologies have been developed to for their 
specific detection with an appropriate sensitivity as 
well as providing a signal in the correct format for the 
readout method required. Despite the vast number 
of amplification methodologies published to date, they are typically achieved through one of the following four approaches; target 
amplification, label amplification, signal amplification or receptor amplification (Figure 1).   
Target amplification involves increasing the number of analyte‒receptor recognition events that occur per analyte. This can be 
done by increasing the analyte concentration prior to analyte recognition through analyte replication protocols, or by recycling the 
analyte after a signal has been produced post-analyte recognition. Additionally, analytes that can affect multiple labels or reporter 
molecules due to possessing catalytic properties themselves provide inherent target amplification within their corresponding 
detection assays. Label amplification focuses on increasing the number of labels per analyte recognition event. Since each label is 
responsible for providing a signal, the ability to amplify the number of labels that represent an analyte‒receptor recognition event 
leads to a signal increase. This can be done using polymerisation or nucleic acid replication techniques or through the use of 
nanostructures, either directly increasing label numbers through multivalency or by providing a collective change in physical 
property to illicit a detectable response. Signal amplification is by far the most common approach to improving the sensitivity of a 
detection methodology and regards the use of amplifiers to enhance the signal produced from an analyte‒receptor recognition 
event. Receptor amplification utilises a number of scaffolds to amplify the amount of receptors bound to the signal-generating 
mechanism. This increases the probability of achieving an analyte‒receptor recognition event and, as a single binding event is able 
to affect the properties of the entire structure; an increased signal can be obtained in comparison to a single receptor system.  
Although the majority of amplification-related publications usually fall within one of the above categories, there are a few that 
are not exclusively bound to such parameters and, for simplification, are categorised by which best defines the approach described 
by the authors. This becomes increasingly apparent in more recent manuscripts where the desire to achieve even greater assay 
sensitivity has been accomplished through a combination of different approaches. 
Target Amplification 
Target Replication 
One strategy to improve the limit of detection (LOD) of an assay is to simply increase the number of target molecules present. If 
only few target molecules are present then an efficient replication technology, specific only to the analyte, would increase the 
Figure 1 Four main approaches to achieving amplification within sensing. 
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concentration of target molecules to a detectable level. 
Traditionally, target replication has been specifically 
developed for the amplification of nucleic acids and 
there have been a substantial number of different 
strategies developed for this purpose.10 One of the most 
widely-known sensing amplification methodology ever 
produced is a prime example of target replication and is 
known as the polymerase chain reaction (PCR).11 
PCR is used to amplify target strands of 
deoxyribonucleic acid (DNA) prior to its detection and is 
carried out over a number of cycles (Scheme 2).12 Each 
cycle begins with denaturation of the double-stranded 
DNA at elevated temperatures in order to obtain the 
target DNA in its single-stranded form. From here, DNA 
primers are then annealed indicating the start of the 
specific sequence of DNA due to be replicated. Starting 
from the primer, an enzyme known as DNA polymerase 
elongates the nucleic acid sequence base-by-base, 
complementary to that of the single-stranded DNA. 
After replication has finished, the cycle is complete and 
two identical copies of double-stranded DNA are 
yielded. These steps can then be repeated until 
amplification yields a detectable concentration of target 
DNA, typically between 15 to 40 cycles. As with every 
PCR cycle the amount of target DNA present is doubled, then DNA amplification through PCR is exponential; one of only a handful 
of sensing methodologies that truly exhibits exponential amplification. Because of this powerful amplification, and the fact that 
the process can be automated using thermal cyclers, PCR has been incorporated into many areas of science where sensitive DNA 
detection is paramount, such as forensics, evolutionary molecular biology and molecular diagnostics.13 Current research into PCR 
has been focused towards avoiding the use of thermostable polymerases and thermal cyclers in order to reduce the time, and 
improve the efficiency of the protocol. A number of isothermal nucleic acid amplification technologies have since emerged,14–15 
which allows for nucleic acid sensing to be performed in the point-of-care (POC) setting.16 One limitation of PCR however is that it 
is specific only to the amplification of nucleic acids. Target amplification methodologies that demonstrate the exponential 
amplification of other analytes as yet remain undiscovered. 
 
Target Recycling 
In the majority of cases, analytes to be detected 
are unable to be replicated as a means of 
providing amplification. Target amplification can 
still be achieved however, if the analyte can be 
recycled after a signal has been produced 
through an analyte recognition event. By doing 
this, one target molecule is able to act upon 
multiple probe molecules that provide the 
detectable signal. This can be described as 
target recycling and is another useful method of 
providing target amplification.  
 One such example of this is enzyme-assisted 
target recycling (EATR) and similarly to PCR, is 
also used primarily for the detection of nucleic 
acids (Scheme 3).17 In this approach, single-
stranded target DNA hybridises with probe 
oligonucleotides, which are usually in a vast 
excess compared with the target. The resulting 
double-stranded DNA is acted upon by an 
enzyme that selectively cleaves the probe and in 
the process, releases a detectable signal.18 
Scheme 2 Target replication: the polymerase chain reaction (PCR) cycle.  
 
Scheme 3 Enzyme-assisted target recycling of nucleic acids. 
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Enzyme-cleavage also results in complex destabilisation, which then undergoes separation releasing the single-stranded DNA 
target capable of reacting further with more probes oligonucleotides. Although EATR produces a linear amplification compared 
with the exponential amplification provided by PCR, fewer false-positives occur since the procedure is less sensitive towards DNA 
contaminants. Additional benefits of EATR over PCR include an improved robustness and reduced cost, making it a useful 
amplification methodology for affordable POC diagnostics. The same concept can also be achieved with ribozymes (nucleic acid 
enzymes) instead of enzymes, allowing for autocatalytic variants of this methodology to become possible.19 
Subsequent improvements to EATR amplification methods have been through the development of self-cleaving probes, thus 
removing the need for enzymes entirely.20 In their non-hybridised form, the probes are stable towards any inter- or intramolecular 
reactions with itself, giving no signal in the absence of the target. In the presence of the target, target-assisted self-cleavage (TASC) 
occurs, destabilising the complex and leading to recycling of the target along with the production of the signal, typically via 
fluorescence. This ‘reagent-free’ approach towards DNA sensing has inspired the development of DNA-templated reactions where 
target DNA can act as a catalyst for turning substrates into products.21 Coupling substrate turnover with signal production allows 
for the reaction to be monitored over time and DNA templates have been shown to provide >200-fold increase in signal within 30 
seconds over a non-templated reaction, and can achieve a turnover number >1500 with a LOD of 0.5 pM.22  
This methodology is not restricted to just the detection of nucleic acids as Huang et al. have recently shown that target recycling 
can be applied to the detection of antibiotics (Scheme 4).23 This amplification procedure actually utilises two recycling pathways 
that operate in sequence to minimise 
background signal production yet deliver 
ultrasensitive detection. For selective 
detection of the target antibiotic, ampicillin, 
the group use a hairpin DNA structure 
containing an aptamer probe. In the 
presence of the target, the hairpin is 
opened allowing the binding of a DNA 
primer and subsequent complementary 
strand replication to occur through the use 
of a polymerase enzyme. This process both 
recycles the target, allowing it to react with 
further probes and produces a double helix 
that then enters its own EATR cycle 
producing multiple copies of short single-
stranded DNA. This amplified sequence is 
then able to bind to electrochemically-
labelled complementary sequences, 
preventing them from being detected at the 
electrode. Thus, a positive sample is 
observed in this case by a signal decrease. 
The use of a DNA aptamer for analyte 
recognition delivered excellent selectivity 
for the target, even in the presence of 
similar structures such as penicillin, and the 
LOD for this system was calculated to be 
1.09 pM after a 4.5 hour amplification 
period which boasts a 100-fold 
improvement over existing methods.  
 These versatile target recycling methodologies have also found use within applications other than sensing. For example, two 
EATR cycles can cross-trigger one another to achieve simultaneous self-amplification for use towards a DNA-based artificial 
biochemical circuit.24 Additionally, cascaded catalytic nucleic acids have been used to control reactivity, perform logic operations 
and assemble complex structures.25 
 
Target Catalysis 
Another target amplification strategy is to utilise any catalytic attributes that the analyte being detected may possess. Therefore, 
target catalysis as an amplification methodology is typically used for the detection of trace metal contaminants found in 
pharmaceutical ingredients and waste water streams. Due to the significant increase in the number of metal-catalysed cross-
coupling reactions used in the pharmaceutical industry over recent years, metal impurities within drug compounds are becoming 
commonplace and are considered to pose a potential health risk.26 Palladium is most commonly used within these processes and 
Scheme 4 Quadratic enzyme-assisted target recycling for small molecule detection. 
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consequently, restrictions have been placed upon the amount of residual palladium allowed to be found in medicinal compounds.27 
Unsurprisingly therefore, the development of sensitive detection methodologies for palladium has been widely sought-after. 
Koide et al. were the first to exploit palladium’s 
catalytic ability as a method of providing 
amplification for its detection.28 Non-fluorescent 
compound 1 was designed with an allyl moiety for 
analyte recognition which, only in the presence of 
Pd0, undergoes deallylation via a Tsuji‒Trost-like 
mechanism (Scheme 5).29–30 Quantitative detection 
of the released, highly-fluorescent product 2 can be 
performed using a standard fluorometer allowing 
for a LOD of less than 1 ppm of palladium per mg 
sample. This efficient example of target 
amplification was successfully shown to detect 
residual Pd0 in pharmaceutical products as well as 
impregnated within used glass reactor vessels. In 
addition, the probe has been used within a high-
throughput method for the detection of palladium 
within ore samples towards the more efficient and 
economical mining of precious metals.31  
As PdII is readily reduced to Pd0, both oxidation states of palladium are detected by this method. However, by changing the 
mechanism used for palladium detection to a metal-catalysed aromatic Claisen rearrangement,32 selective detection of PdII over 
Pd0 could be achieved.33 The similar reactivity of palladium and platinum however can cause selectivity issues, but through  careful 
selection of the solvents used in the assay and by maintaining a specific pH, this can also be overcome.34 Improvements to this 
detection methodology include the introduction of reducing agents and phosphine ligands in order to increase the catalytic activity 
of the palladium, which in turn leads to increased sensitivity of the assay.35–36 Furthermore, a bis-allyl ether derivative of 1 has 
been very recently reported that can significantly reduce background fluorescence and as such, delivers a >300-fold signal increase 
within a 5 minute reaction period.37 
Alternative moieties have also been shown to be selective for palladium detection as a propargyl derivative of compound 1 has 
been shown to be able to monitor palladium accumulation in living systems via fluorescence.38 Probes with different fluorescent 
scaffolds have also been used for palladium detection within cells.39,40 Among these, naphthalimide-derived probes are considered 
the most accurate since fluorescence detection is ratiometric.41 Palladium sensing is not confined to just allyl or propargyl 
deprotection as Jun and Ahn have utilised the catalytic cross-coupling capability of palladium to develop a ‘switch-on’ fluorescent 
detection method (Scheme 6).42 In this example of target catalysis, non-fluorescent probe 3 was designed comprising of an aryl 
iodide for analyte recognition and a spirolactam derivative of a rhodamine dye, a common pro-fluorescent scaffold.43 Oxidative 
insertion into the carbon‒halide bond induces ring-opening of the spirolactam, and subsequent reductive elimination provides 
highly-conjugated fluorescent product 4 
whilst simultaneously regenerating the target. 
This highly sensitive technique allows for the 
specific detection of palladium at 
concentrations as low as 2 ppb. Following the 
success of these initial reports, there has been 
extensive research into the development of 
alternative probes for both the colourimetric 
and fluorescent detection of palladium and 
platinum based upon this catalytic 
amplification concept.44–45 
The use of target catalysis for the 
detection of other metals that also 
demonstrate catalytic activity have similarly 
been attempted. For example, both the 
Koide,46–47 and Ahn,48 groups have employed 
their switch-on fluorescence sensing 
methodologies for the detection of mercury. 
Since Hg2+ selectively activates alkynes and 
vinyl ethers towards hydrolytic cleavage, 
protecting their respectively-developed 
Scheme 5 Fluorogenic detection of palladium using a catalytic deprotection strategy.  
Scheme 6 Fluorogenic detection of palladium using a catalytic cross-coupling strategy. 
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fluorophores with these functional groups would give access to non-fluorescent mercury substrates. Although this is indeed the 
case, the mechanism for the mercury-promoted ether cleavage is not catalytic and involves consumption of the metal ion, usually 
released as an organomercury compound. As the target does not exhibit catalytic attributes, target catalysis is not observed in 
these cases and thus, fall outside the scope of this review. Other sensing methodologies which appear to employ target catalysis, 
such as the fluorescent detection of Co2+,49 Cu+,50 and Cu2+,51 actually require super-stoichiometric amounts of the analyte to 
deliver full signal switch-on. 
After the definition of “click” chemistry was proposed,52 the copper-catalysed alkyne–azide cycloaddition (CuAAC) reaction,53‒
54 a catalytic derivative of the cycloaddition originally developed by Huisgen et al.,55 has become the synonymous example and has 
been employed within numerous applications over recent years.56 Manipulation of non-fluorescent reagents to afford a highly 
fluorescent product under the reaction conditions has led to the development of the fluorogenic click reaction.57 Although not 
specifically designed for sensing, this methodology does utilise target catalysis to generate an amplified fluorescent product in the 
presence of catalytic amounts of copper. Due to the efficiency of CuAAC, Q. Wang et al. could screen a large range of coumarin,58 
and anthracene,59-derived profluorophores in a combinatorial fashion to quickly identify which coupling partners combine to give 
products with the highest quantum yields. As the functional groups are inert and stable under biological conditions, as well as the 
high yields and excellent regioselectivity of the reaction, this reaction has understandably been designed for biolabelling purposes 
and protocol has contributed significantly towards the development of reaction-based small-molecule fluorescent probes used for 
chemoselective bioimaging.60  
In addition to the sensitive detection of metals, the detection 
of enzymes are equally important especially within high-
throughput screening for drug discovery as well as enzyme 
engineering.61 Since a single enzyme is capable of generating 
multiple reporter molecules, amplification in the form of target 
catalysis is inherent within enzyme detection assays.62 The 
simplest and most effective strategy is to couple enzyme-
responsive functional groups with water-soluble chromogenic or 
fluorogenic moieties to obtain enzyme substrates that selectively 
exhibit a change in physical property in the presence of an 
enzyme.63 For example, Sames et al. designed a range of 
fluorogenic probes for oxidoreductase enzyme detection based 
on this concept.64 During their investigation, they found that one 
probe in particular was a highly selective substrate for 3-α-
hydroxysteroid dehydrogenase (HSD), an enzyme responsible for 
the activation and deactivation of steroid hormones.65 This 
enabled fluorescence imaging to be performed on human cells in 
order to monitor the up-regulation of HSD in response to panaxytriol,66 an active compound found in red ginseng; a common 
ingredient within herbal medicines.67 
By changing the enzyme-responsive trigger unit, 
the group were able to simply achieve a highly 
selective ‘switch-on’ fluorescent assay for 
monoamine oxidase (MAO) (Scheme 7),68 an enzyme 
associated with neurological and psychiatric 
diseases.69 In this enzyme detection assay, 
compound 5 was exposed to MAO which catalyses 
the aerobic oxidation of amines to the 
corresponding imines.70 Imine 6 is then hydrolysed 
under the aqueous conditions required for enzyme 
activity to give aldehyde 7, which then undergoes 
intramolecular cyclisation and dehydration to afford 
highly fluorescent indole 8. Although not a 
particularly sensitive system due to the slow 
turnover rate of the enzyme, it did allow for the 
direct and continuous measurement of MAO activity 
in mitochondria, utilising target catalysis for 
amplification.  
Although comprising the significant majority, 
enzyme detection methods are not solely achieved 
using colour or fluorescent signal production. 
Scheme 7 Fluorogenic enzyme assay for the detection of MAO. 
Scheme 8 Electrochemical enzyme assay for the detection of aldolase activity.  
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Electrochemistry has been gaining significant popularity due to increased specificity, speed, portability and low cost in comparison 
with the aforementioned optical detection techniques.71 In addition, samples do not need to be purified or transparent prior to 
detection, the instruments does not require complex calibration to maintain accuracy and miniaturisation has allowed 
electrochemical detection to be easily incorporated into point-of-care (POC) biosensors.72 
 An example of target catalysis used for amplification within an electrochemical detection assay can be provided by Shabat et 
al. for monitoring aldolase activity (Scheme 8).73 In this development, ferrocene-labelled substrate 9 was synthesised and exposed 
to a catalytic antibody that expresses aldolase activity. In its presence, substrate 9 first undergoes a retro-aldol reaction to afford 
compound 10, followed by a retro-Michael elimination to give carbamic acid 11. Under the assay conditions, this unstable acid 
spontaneously decarboxylates to achieve aminoferrocene 12. Importantly, substrate 9 and product 12 were found to have 
significantly different oxidation potentials and as such, could be distinguished electrochemically. Despite requiring two enzyme-
catalysed reactions to afford the detectable product, current changes could still be measured at an antibody concentration as low 
as 0.33 µM. This elegant procedure can also be extended to the ratiometric electrochemical detection of other enzymes such as 
alkaline phosphatase (ALP) through simple modification of the enzyme-responsive functional group upon the substrate.74 
Label Amplification 
Since the majority of analytes requiring 
detection do not possess catalytic attributes 
or can be easily replicated, target 
amplification is therefore a difficult 
amplification strategy to successfully 
implement. An alternative approach is to 
amplify the number of signal-producing 
labels that correspond to an analyte‒probe 
recognition event. The concept is simple; 
increasing the number of signal-producing 
labels per analyte recognition event would 
lead to an amplified signal output compared 
with a single-labelled probe. The concept 
was successfully demonstrated exemplified 
by Ternon and Bradley who developed an 
amplified assay for fluorescent protease 
detection through the use of multiple valent 
fluorophores (Scheme 9).75 
 In this approach, Förster resonance energy 
transfer (FRET) was utilised through the 
construction of peptide substrate 13 
containing a tri-fluorophore label at one end 
and a fluorescence quencher at the other.76‒
77 Thus, in the absence of the enzyme target, 
intramolecular fluorescence quenching 
occurs and a fluorescent signal is therefore 
not observed. However, in the presence of 
the target protease, trypsin, cleavage of the peptide occurs which fragments the substrate preventing intramolecular quenching 
from occurring and consequently, a fluorescent signal is observed. In comparison to a single fluorophore-labelled substrate, 
compound 13, which contains three fluorophores, was capable increasing the signal-to-noise ratio of the assay by a factor of 4.6. 
Although amplification was observed through this method, the assay is limited by the number of fluorophores bound to the 
substrate, in this case just three. As such, label amplification methodologies developed since have looked at alternative ways at 
increasing the number of labels per analyte‒probe recognition event and typically, these methods are found to be more effective 
when employed after such an event.  
 
Label Replication 
One approach to providing label amplification is to apply a replication methodology subsequent to an analyte‒probe recognition 
event where the probe is labelled with an easily-replicated moiety. Similarly to target amplification approaches, nucleic acid 
replication methodologies are ideal and a derivative of PCR known as rolling circle amplification (RCA) is commonly used.78 RCA is 
an isothermal nucleic acid amplification protocol which has found use in many applications within chemical biology, materials 
science and medicine.79 Typically, circular single-stranded DNA, called a template, is linearly replicated hundreds or thousands of 
Scheme 9 FRET enzyme assay for the detection of trypsin. 
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times to give an extremely long strand of single-stranded DNA. Since the same DNA sequence is repeated, multiple complementary 
probe strands are able to hybridise to the amplified single-stranded DNA label enabling sensitive detection normally through 
fluorescence.80 
 The application of RCA to immunoassays, 
known as immuno-RCA, allows for the 
sensitive detection of proteins through the 
labelling of probe antibodies with a specific 
DNA sequence (Scheme 10).81 In the 
presence of the analyte, hybridisation with 
the circular template enables replication of 
the label DNA sequence using RCA, which 
can then be detected by fluorescence 
through the hybridisation of multiple 
complementary DNA sequences tagged 
with a fluorophore. This strategy allows for 
an enormous ratio of fluorescent molecules 
per label, and therefore per analyte, and as 
such, delivers a highly sensitive detection 
system. Jiang et al., for example, achieved a 
LOD of 0.9 fM for the detection of human 
immunoglobulin G (IgG) using immuno-
RCA.82 
RCA has also been combined with 
oligonucleotide-functionalised nanoparticles for sensitive cancer cell detection by electrochemical methods with an obtained LOD 
of 10 cells per mL.83 Increasing the sensitivity of DNA-labelled immunoassays can also be achieved by using PCR as the amplification 
technique.84 Termed immuno-PCR, this technique delivers 100 to 10000-fold increase in immunoassay sensitivity and has been 
applied to the sensitive detection of tumour markers, viral proteins and bacterial pathogens.85–86 However, to allow the label to 
be amplified by PCR, cleavage of the DNA label from the analyte‒probe complex is required which can be difficult to perform 
efficiently without denaturising the complex and creating unwanted contaminants that can hinder the PCR amplification process. 
 A reagentless label replication strategy 
known as the hybridisation chain reaction 
(HCR) was developed by Dirks and Pierce, that 
involved two stable DNA hairpin structures 
that can coexist in solution until selectively 
triggered by the analyte.87 Once triggered, the 
two strands of DNA react with one another in 
an alternating end-over-end fashion. By 
introducing 2-aminopurine (2AP), a 
fluorescent adenine analogue,88 into the 
structure of one of the hairpin structures, HCR 
can be measured through fluorescent 
quenching. Alternatively, labelling both ends 
of both hairpin structures with pyrene enables 
a switch-on fluorescent DNA detection 
derivative (Scheme 11).89 Not only is this 
amplification method isothermal and enzyme-
free, it is also both highly selective, as base-
pair mismatches, base deletion or base 
insertion are all discriminated from the target, 
and highly sensitive as DNA detection is in the 
femtomolar range. These highly 
advantageous attributes has enabled HCR to be used for in situ amplification and fluorescent imaging within vertebrate embryos.90 
The versatility of such an approach has also been demonstrated as by replacing the pyrene labels with nanoparticles, the detection 
of nucleic acids,91 as well as enzymes,92 can be achieved using electrochemical methods.  
Scheme 10 Label amplification using RCA in a DNA-labelled immunoassay. 
Scheme 11 HCR approach to label amplification. 
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A synthetic approach to label replication 
was developed by Bowman et al. who 
achieved an amplified response through 
molecular recognition-selective 
polymerisation (Scheme 12).93 In this 
approach, surface-bound biotin-labelled 
analytes are tagged with a 
macrophotoinitiator via an avidin complex. 
Irradiation of the surface in the presence of a 
monomer-containing solution induces 
polymerisation selectively from the 
photoinitiators, which therefore only occurs 
in the presence of the analyte. A 10 minute 
exposure to 365 nm wavelength light was 
enough to initiate polymers with a thickness 
greater than 100 nm, which is significant 
enough to see with the unaided eye and 
allowed a DNA concentration of 0.5 fmol to 
be easily detected. It has been estimated 
that an amplification factor of between 106 to 107 can be achieved through this methodology.94 This polymerisation-based 
amplification has also been applied to the detection of the influenza virus through macrophotoinitiator-labelled immunoassays.95 
To provide quantitative measurements, as opposed to the quantitative visual readout, fluorescent nanoparticles can also be 
incorporated into the polymer enabling DNA detection,96 and antibody detection,97 to be achieved through fluorescent 
polymerisation-based amplification. 
 In a conceptually opposite approach, self-
immolative polymers that undergo triggered 
depolymerisation in the presence of a specific 
analyte have been developed by Shabat et al. for 
catalytic protein detection (Scheme 13).98 
Typically, polymer chains comprised of between 
15‒20 pro-fluorescent monomer units and an 
analyte-responsive trigger unit at the head were 
synthesised. Cleavage of the head group occurs 
selectively in the presence of bovine serum 
albumin (BSA),99 triggering continuous head-to-
tail depolymerisation,100 with subsequent release 
of the monomer units and trapping of these aza-
quinone-methide intermediates 16 with water, 
generates aniline 17 with a consequential turn-on 
of fluorescence. Although full consumption and 
full elimination of the polymers is slow, a 1 
mgmL−1 concentration of BSA could easily be 
distinguished from the background after an hour. 
Different monomers can easily be incorporated into the polymer allowing multiple signals to be released simultaneously upon a 
single trigger cleavage.101 This has led to self-immolative polymers being used for a number of biomedical applications as well as 
for amplification within diagnostic assays.102–103 
 
Label Multiplication 
In the majority of instances, label replication is typically restricted to the use of nucleic acids as labels as it relies upon nucleic acid 
amplification procedures such as PCR and RCA. However, these methods are dependent upon the successful conjugation of the 
DNA label to the antibody, which can be difficult to achieve without denaturising the antibody. Also, polymerisation methods can 
be irreproducible and quantification of analyte concentrations can be difficult. A more general approach to providing label 
amplification can be provided though multiplying the number of labels present after an analyte‒receptor recognition event. In this 
method, the label that indicates the presence of the target is able to capture multiple identical probes in the adjacent vicinity, thus 
multiplying the number of labels per target. This is exemplified by an amplification procedure designed to increase 
immunosensitivity known either as tyramide signal amplification (TSA),104 or catalysed reporter deposition (CARD).105 
Scheme 12 Polymerisation-based label amplification. 
Scheme 13 Integer label amplification through triggered head-to-tail depolymerisation. 
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Typically, CARD is used to multiply the 
number of enzyme labels that represent the 
presence of a target protein after an initial 
analyte‒receptor complex has been labelled 
with an enzyme (Scheme 14).106 In this 
example, the target analyte is bound to a solid 
surface and identified with the corresponding 
antibody labelled with the enzyme 
horseradish peroxidase (HRP). In the presence 
of a biotin-labelled tyramine-derived 
substrate, the enzyme catalyses the formation 
of highly reactive tyramine radicals that react 
readily with any tyrosine units found within 
the adjacent protein structures.107 This results 
in the macromolecular structure being 
covered with many biotin molecules, each of 
which is able to bind another enzyme via its 
streptavidin conjugate utilising the high 
binding affinity between biotin and 
streptavidin.108 By employing this approach, 
one target is able to bind multiple enzyme 
labels which, upon addition of a pro-
fluorescent substrate, leads to an amplified 
fluorescent output. This method is reported to 
deliver improved sensitivity in comparison to 
other probe multiplication methods towards 
increasing immunoassay sensitivity such as 
the avidin‒biotin complex (ABC) approach.109 
 The ABC approach to label multiplication typically utilises the multivalent characteristics of the streptavidin tetramer avidin, 
in order to increase the number of labels that represent a target molecule (Scheme 15).110 Similarly to CARD, target proteins are 
identified by appropriate antibodies after to being adsorbed onto a solid surface. Instead of being labelled with an enzyme 
however, the antibodies are labelled with biotin. The addition of a solution consisting of avidin and biotin-labelled HRP leads to a 
vast interlinked biotin‒avidin network containing 
multiple peroxidase enzymes per complex. As a 
result, when the enzyme network is exposed to a 
solution containing the enzyme substrate, an 
amplified response is observed compared to an 
immunoassay that uses just one enzyme per 
target analyte. This has led to the ABC approach to 
label amplification to be used for a number of 
applications such as affinity chromatography and 
enzyme localisation studies, as well as for 
diagnostics.111 However, like many immunoassay 
amplification methodologies, this system is 
susceptible to high background rates due to non-
specific adsorption. Not only this, but the 
procedure also adds multiple manipulation steps 
in comparison to standard immunoassays.112 
The concept of synthesising structures possessing multivalent characteristics in order to multiply the number of labels 
corresponding to a single target molecule has inspired the development of many other label amplification approaches. In 
particular, nanostructures have found considerable success as label amplifiers, especially within biosensors, due to their small size 
yet large collective surface area.113–115 For example, Rusling et al. described the use of carbon nanotubes as the label amplifier 
within an electrochemical immunosensor for sensitive cancer biomarker detection.116 In this approach, the carbon nanotubes 
function as a bridge between the antibody used for target identification, and the enzyme labels. The amount of enzyme labels per 
binding event was calculated to be approximately ninety, which allowed for a LOD of 4 pgmL−1 for the cancer biomarker, prostate 
specific antigen (PSA). Similarly, this technique was also used for the attomolar detection of DNA, which equates to  just 80 
copies.117 Gold nanoparticles, which are easier to functionalise than carbon nanotubes, have also been used as the label amplifier. 
Scheme 14 Catalysed reporter deposition (CARD). 
Scheme 15 Avidin‒biotin complex (ABC) approach to label amplification.  
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The enzyme label to binding event ratio was 
found to dramatically increase through this 
change, since the use of 1 µm diameter gold 
nanoparticles allowed up to five hundred 
thousand enzyme labels to be attached per 
nanoparticle. Due to this massive label 
amplification, a LOD of 1 fgmL−1 was 
obtained for the detection of cancer 
biomarker interleukin-8 (IL-8).118 
The ability to attach a large number of 
labels upon a single nanoparticle and that 
gold nanoparticles in particular are easier to 
functionalise through strong covalent gold–
thiol bonds, has seen them incorporated 
into a large number of chemical and 
biological sensing methodologies for label 
amplification.119 One extremely sensitive 
approach was developed by Mirkin et al. 
who functionalised gold nanoparticles with 
multiple copies of oligonucleotides with 
identical sequences to obtain what are 
known as “bio-barcodes”.120 These bio-
barcode nanoparticles were then used as 
label amplifiers for the sensitive protein 
detection (Scheme 16).121 In this approach, 
antibody-functionalised magnetic capture 
nanoparticles are used to identify target proteins which, in the presence of the analyte, are labelled with the bio-barcodes through 
the formation of a highly-stable sandwich complex. The complex is then separated from the mixture magnetically and the 
oligonucleotide labels are released from the nanoparticle either thermally by hydrolysis or chemically, using dithiothreitol (DTT).122 
If necessary, the relea sed oligonucleotides can also be amplified by PCR to further increase the sensitivity of the assay. Detection 
is often achieved scanometrically on a solid surface,123 or by fluorescence in solution using fluorophore-labelled probes.124 By 
functionalising the magnetic capture nanoparticle with DNA instead of antibodies, the bio-barcode sensing approach can be 
applied towards DNA detection. The sensitivity of this approach allows for target DNA detection with a LOD of 0.5 aM, which 
approximately equates to just 10 copies of DNA per 30 µL sample.125 The bio-barcode amplification approach also exploited the 
versatility of nanoparticles through the simultaneous use of magnetic capture nanoparticles with different probes and different 
label nanoparticles which allows for the multiplex detection of either DNA,126 or proteins.127 
 
Label Aggregation 
Another approach to label amplification 
can be demonstrated by an analyte’s ability 
to affect a large number of labels in a 
collective fashion, as opposed to amplifying 
the label post an analyte‒probe recognition 
event as seen in replication or 
multiplication strategies. Rather than 
having one reporter molecule being made 
responsible for the production of the signal 
with amplification efforts being made to 
increase the number of these molecules 
per analyte, it is the strategy of label 
aggregation to harness all the reporter 
molecules available to create the signal and 
by changing the physical properties of a 
collective signal in the presence of the analyte, significant amplification can be achieved. This type of collective response to minor 
changes in conditions is analogous to colourimetric pH indicators where a slight increase or decrease in acidity is enough to shift 
the equilibrium of the system, which can result in a dramatic colour change. In a similar manner, the optical properties of gold 
Scheme 16 Detection of a target protein using nanoparticle-based bio-barcode probes. 
Scheme 17 Gold nanoparticle label aggregation for colourimetric DNA detection. 
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nanoparticles are known to be dependent upon the distance between each nanoparticle, which is attributed to the surface 
plasmon resonance (SPR) of gold.128 Manipulation of this physical property phenomenon for label aggregation within a sensing 
methodology was first provided by Mirkin et al. for the colourimetric oligonucleotide detection (Scheme 17).129 
 In this approach, ≈13 nm gold nanoparticles were constructed and derivatised with mercaptoalkylated probe oligonucleotides 
to afford a nanoparticle-containing solution with a characteristic red colour since the distance between particles is significantly 
greater than the particles themselves. In the presence of target oligonucleotides, hybridisation at both ends of the target causes 
significant aggregation of the nanoparticles and the subsequent decrease in interparticle distance results in a colour change to 
blue. This simple DNA detection and label amplification method was found to be surprisingly selective as a single base-pair 
mismatch could be distinguished from the complementary target. Sensitivity was also high allowing for a LOD of ≈10 fM of 
oligonucleotide to be easily detected. 
  In a similar but opposite approach, 
Liu and Lu utilised the disaggregation of 
gold nanoparticles towards colourimetric 
lead ion detection (Scheme 18).130 In this 
setup, an oligonucleotide probe was used 
to aggregate gold nanoparticles together 
through hybridisation at both ends. In the 
presence of lead, inert DNAzymes are 
activated which results in cleavage of the 
oligonucleotide substrate serving as the 
linkage between the nanoparticles. The 
dissociation of the nanoparticles results in 
an easily-visualised colour change from 
blue to red. Since DNAzymes can be 
synthesised to be very selective for 
particular cofactors,131 this method was 
shown to be highly selective for lead in the 
presence of a host of other metal ions. The 
label aggregation provided by this 
methodology provided excellent sensitivity 
with a LOD of 100 nM lead concentration 
shown to be detectable by the unaided eye.  
Gold nanoparticulate label amplification has also been applied to enhancing the sensitivity of enzyme-linked immunosorbent 
assays (ELISAs). ELISAs are typically protein detection assays that were initially developed as a safer and inexpensive alternative to 
immunoradiometric assays (IRMA) that used radioactive labels.132 Indirec t or ‘sandwich’ ELISA is the most common format of 
choice for medical diagnostics as although requiring extra steps in the protocol compared with other formats, it is the most 
selective since the procedure utilises two antibodies; one absorbed onto the solid-phase for antigen capture and another 
conjugated to an enzyme for antigen labelling.133 To increase ELISA sensitivity, de la Rica and Stevens developed a plasmonic ELISA 
for the visual detection of disease biomarkers 
(Scheme 19).134 
 In this example, a traditional sandwich ELISA 
labelled with catalase, an enzyme that catalyses 
the breakdown of hydrogen peroxide, was 
constructed. In the presence of the target, and 
therefore the enzyme, hydrogen peroxide is 
broken down to water and molecular oxygen 
which allows the solution containing Au3+ ions to 
form ill-defined nanoparticles that aggregate 
together leading to a blue colour to be 
developed. In the absence of the target, 
hydrogen peroxide remains in solution and 
reduces the Au3+ ions in the solution to Au0. This 
leads to the formation of regular, spherical 
nanoparticles that do not aggregate together 
and cause a red colour to be developed. This 
example of gold nanoparticle label amplification 
in conjunction with enzyme signal amplification 
Scheme 18 Gold nanoparticle label deaggregation for colourimetric lead detection. 
Scheme 19 Plasmonic ELISA employing gold nanoparticulate label amplification for the 
colourimetric detection of disease biomarkers. 
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 13  
Please do not adjust margins 
Please do not adjust margins 
allowed for a LOD of 1 agmL−1 for the 
detection of PSA and enabled the visual 
detection of HIV antigens at concentrations 
that were undetectable by a traditional 
nucleic acid-based test. This has since given 
rise to the development of a number of 
biodiagnostic tests that utilise plasmonic 
nanomaterials for both amplification and 
signal production.135 However, successful and 
accurate signal production is highly 
dependent on a freshly prepared and precise 
concentration of hydrogen peroxide.136 
 Another example of gold nanoparticulate 
label amplification being applied to protein 
detection has been described by Jiang et al., 
who used copper oxide nanoparticle labels to 
catalyse the aggregation of gold 
nanoparticles for the detection of human immunodeficiency virus (HIV) antigens (Scheme 20).137 Here, a direct immunoassay was 
constructed where the antigen was adsorbed onto the surface of the microtitre well and identified first with a primary antibody, 
then with a secondary antibody tagged with copper oxide nanoparticles. In the presence of the nanoparticles, and therefore the 
analyte, the introduction of a strong, acidic solution to the assay dissolves the copper nanoparticles, releasing Cu2+ ions into the 
system. Once released, the Cu2+ ions can catalyse a click reaction between two sets of gold nanoparticles; one set covered with 
terminal alkynes and the other covered with alkyl azides.138 After a significant number of gold nanoparticles have been knitted 
together, the aggregation causes the colour of the solution to change from red to blue. In the absence of the antigen, the copper 
catalyst is not produced and the gold nanoparticles remain separate keeping the detection solution red. Although not explicitly 
stated, the LOD obtained for this detection method was said to rival that of a traditional fluorescence ELISA. 
 Label multiplication methods such as CARD and the ABC approach both suffer from a lack of versatility as there are only a 
limited number of labels available for amplification. Nanostructures compensate for this as their versatile nature has made them 
popular label amplification tools within biosensing. However, they are often cumbersome to prepare and suffer from high 
backgrounds due to oversensitivity from non-specific adsorption. The use of controlled aggregation for label amplification is a 
simple yet effective strategy for amplification within sensing and typically has the benefit of a colour change which can be easily 
visualised. Despite having examples exhibiting powerful amplification, label amplification techniques are often analyte-specific 
and are restricted to the specific type of diagnostic assay they are designed for in order to achieve successful amplification. 
Signal Amplification  
Signal amplification is the process whereby the 
signal generated from an analyte‒probe 
recognition event is amplified by an external 
amplifier. In this context, an amplifier is 
considered as a component which can produce or 
turnover multiple reporter molecules per 
amplifier and are therefore typically synthetic 
catalysts or enzymes. Since no such amplification 
component under this description is apparent 
within many simple turn-on fluorescence or 
colourimetric assays, these sensing 
methodologies predominantly used within 
molecular logic gate systems,139‒142 indicator 
displacement assays (IDAs),143‒145 and reaction-
based indicator systems,146 are therefore 
excluded from this review. These particular 
classes of assay have become subject of a number 
of specific, recent reviews and readers interested 
in these areas are directed towards the 
respective references. 
Scheme 20 Copper oxide nanoparticle-labelled immunoassay employing gold nanoparticulate label 
amplification for colourimetric HIV antigen detection. 
Figure 2 Four main approaches towards molecular signal amplification.  
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Signal amplification is the most popular 
amplification method employed in sensing as 
it is often the easiest amplification 
methodology to design and implement, as 
amplification does not involve amplifying the 
target or the label. Due to the high number of 
examples, signal amplification approaches can 
be divided into four distinct areas based on the 
mechanism of amplification: single-catalyst, 
double-catalyst, autoinductive and 
autocatalytic (Figure 2). As one would expect, 
the reaction profiles displayed by these signal 
amplification mechanisms are typically 
markedly different (Figure 3). However, it is 
not a case of which one provides the biggest 
or fastest signal as, dependent upon the 
application, one type of signal amplification 
may prove more suitable than another.  
 Initial developments towards 
implementing signal amplification within 
diagnostic assays were focused upon using a 
single amplifier such as an enzyme or a catalyst, which provides a linear increase in signal over time. A natural succession from this 
led to the successful combination of two consecutive signal amplifier s to achieve dual-enzyme, dual-catalyst or even hybrid 
enzyme‒catalyst amplification cascades, which often display quadratic-type amplification profiles. The constant strive to attain 
even greater assay sensitivity has led to the development of complex auto-amplification strategies, such as autoinductive and 
autocatalytic signal amplification, where the signal-amplified products themselves can increase the rate of signal production. 
Autoinductive signal amplification is a system whereby the products can indirectly accelerate the rate of a kinetically meaningful 
step of the signal amplification mechanism whereas autocatalytic signal amplification is the process whereby the products 
themselves directly serve as catalysts for their own production.147 As a result, both auto-amplification types exhibit sigmoidal 
amplification profiles with autocatalysis demonstrating exponential signal amplification. Again, choosing the appropriate signal 
amplification protocol for a diagnostic assay is dependent upon a number of factors including, but not limited to, the type of 
analyte being detected, the medium the amplification is being performed in, the length of time after analyte recognition that a 
signal is required and the readout method used. For example, an assay requiring the lowest LOD possible would look to elect an 
autocatalytic signal amplification method whereas an assay requiring greater accuracy would look to employ a single-catalyst signal 
amplification strategy. 
 
Single-Catalyst Signal Amplification 
Signal amplification methodologies typically 
use enzymes or synthetic catalysts as 
amplifiers due to their ability to generate 
multiple product molecules without 
themselves being chemically altered. By 
designing a detection system whereby the 
enzyme or catalyst indicate the presence of 
the target and product formation results in a 
change in physical property, then catalyst or 
enzyme activity, and therefore the target, can 
be easily detected.148 As such, early signal 
amplification methodologies focused on the 
selective activation of the amplifier in the 
presence of the target analyte. Typically, this is 
achieved either through intrasteric or 
allosteric activation.  Intrasteric activation 
involves direct competition between the 
analyte and an inhibitor for the catalyst or 
enzyme active site and allosteric activation 
Figure 3 Typical signal amplification profiles observed for the different signal amplification 
mechanisms. 
Scheme 21 Intrasteric enzyme activation through steric repulsion for signal-amplified protein 
detection. 
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involves structural alteration of amplifier conformation which results only from recognition of the analyte at a site on the amplifier, 
other than the active site.149 Examples of both allosteric and intrasteric activation of enzymes, as well as allosteric and intrasteric 
activation of synthetic catalysts have all been successfully demonstrated for the detection of a wide variety of analytes.  
 The very high turnover rate of enzymes under physiological conditions have made them popular signal amplifiers within sensing 
methodologies and varying enzyme activation methods have been employed to enable selective analyte detection. Intrasteric 
activation of enzymes is one particular method of activation and works through initial blocking of the active site of the enzyme 
with an inhibitor which restricts enzyme activity. Removal of the inhibitor by an analyte-recognition event restores enzyme activity 
which can be detected by the addition of an appropriate enzyme substrate. A very recent development by Tan et al. provides a 
perfect example where the activity of human carbonic anhydrase (HCA) is intrasterically regulated through a strongly bound 
benzenesulfonamide inhibitor which is labelled with a protein-specific tag (Scheme 21).150 In the presence of the target protein, a 
binding event with the tag occurs which plucks the inhibitor out of the HCA active site in order to minimise steric interactions 
between the protein and the enzyme. Enzyme activity is thus restored and can be measured by the fluorescence emission of 
fluorescein 19 produced from the enzyme-catalysed hydrolysis of non-fluorescent substrate, fluorescein diacetate (FLDA) 18. The 
use of an enzyme for signal amplification was found to increase fluorescence signals 70-fold. This versatile approach was 
demonstrated for the detection of a number of different proteins through simple alteration of the inhibitor tag. 
 Another method towards intrasteric enzyme activation for 
protein detection has been demonstrated by Rotello et al. 
who developed a procedure known as enzyme-amplified 
array sensing (EAAS) (Scheme 22).151 In this method gold 
nanoparticles deliberately developed to possess a high 
cationic surface charge,152 electrostatically bind to enzymes 
such as β-galactosidase (β-gal) that have a high anionic 
surface charge, and inhibit enzyme activity without 
denaturing the enzyme.153 In the presence of specific 
proteins, the nanoparticles blocking the active site of the 
enzyme are removed, which restores enzyme activity. The 
addition of pro-fluorogenic substrate, 4-methylumbelliferyl-
β-D-galactopyranoside (4-MUG) 20, allows for protein 
detection via fluorescence. The amplification provided by the 
enzyme delivers a highly sensitive detection assay able to 
differentiate target proteins at 1 nM concentrations. The 
versatility of using enzymes as amplifiers under physiological 
conditions is also demonstrated as using an alternative 
enzyme substrate enabled a colourimetric biosensor for 
bacterial infections to be developed.154 Furthermore, this 
electrostatic nanoparticle approach to protein detection can 
be used in conjunction with fluorescent conjugated polymers, 
vide infra, to develop ‘chemical nose’ sensors capable of distinguishing between several different proteins simultaneously.155 
 Enzymes have also been used in a number of amplified nucleic 
acid detection methodologies due their ease of conjugation to 
DNA as well as rapid signal production.156 One of the first examples 
of such a system was described by Ghadiri et al. who developed a 
modified protease enzyme where its phosphoramidate inhibitor 
was covalently bound to itself through a single-stranded DNA 
probe (Scheme 23).157 Once constructed, the modified enzyme 
was rendered inactive since the flexibility of the DNA probe 
allowed for the inhibitor to loop around and bind to the active site 
of the enzyme. In the presence of target DNA, hybridisation occurs 
forming a highly favourable rigid DNA duplex and in the process, 
physically removes the inhibitor from the active site of the 
enzyme. Enzyme activity is therefore restored and hydrolysis of a 
non-fluorescent substrate to a fluorescent product enables simple 
enzyme-amplified DNA detection via fluorescence. Both the 
sensitivity and selectivity of the concept was validated as a 10 pM 
concentration of DNA could be detected within 3 minutes and no 
discernible signal was observed in the presence of non-
complementary DNA. Additionally, this approach is not limited to 
Scheme 22 Protein detection via intrasteric enzyme activation through 
electrostatic interactions. 
Scheme 23 DNA detection via allosteric enzyme activation through 
intrasteric enzyme regulation. 
ARTICLE Journal Name 
16 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
the use of proteases for signal amplification 
as the enzyme thrombin has also been 
conjugated to an inhibitor‒DNA probe for 
fluorescent DNA detection.158 The excellent 
control of enzyme activity demonstrated 
through allosteric regulation allows for 
molecular logic gates to be developed, 
operated by different DNA sequences.159 
 Enzyme and inhibitor do not necessarily 
have to be covalently bound at either end 
of the same single-stranded DNA probe in 
order to achieve successful intrasteric 
enzyme activation as Merkx et al. have very 
recently demonstrated (Scheme 24).160 In 
this approach, β-lactamase and a β-
lactamase inhibitory protein (BLIP) were 
attached to separate strands of DNA that were complementary to that of the probe strand. Through a strong hybridisation 
interaction and the flexibility of the single-stranded probe strand, enzyme and inhibitor are brought together restricting substrate 
turnover. In the presence of target DNA, hybridisation with the probe strands causes significant structural rigidity and physically 
pulls the inhibitory protein from the enzyme active site and away from one another, thus restoring enzyme activity. Again, this can 
be measured by fluorescence through the introduction of a non-fluorescent enzyme substrate to afford the fluorescent product. 
This modular approach to intrasteric enzyme activation for sensitive DNA detection could detect down to 2 fmol of target single-
stranded DNA. 
 Enzyme activity can also be regulated through selective control of specific allosteric factors. In principle, allosteric activation 
involves target analyte recognition at an allosteric binding site which, in turn, causes a structural conformation that activates the 
catalyst. The excellent versatility of being able to regulate enzyme activity through allosteric activation, rather than intrasteric 
activation, has seen this method used extensively for signal amplification within biosensors for molecular diagnosis.161 Allosteric 
enzyme activation methods can vary tremendously, but generally either occurs through manipulation of enzyme cofactors or 
through modification of the enzyme structure. Enzymes are usually dependent upon cofactors, such as small organic molecules,162 
or metal ions,163 for high catalytic activity. Therefore, a popular allosteric enzyme activation method for sensing is to release 
enzyme cofactors selectively through an analyte‒probe interaction at an allosteric binding site to consequently up-regulate 
enzyme activity.  
 Through the manipulation of flavin, a small organic 
molecule cofactor, Décout et al. have also developed an 
allosteric enzyme activation method for fluorescent DNA 
detection (Scheme 25).164 Modifying flavin with a single-
stranded DNA probe was shown not to significantly 
interfere with its ability to act as a cofactor, thus enzyme 
activity remained on consuming fluorescent substrate, 
nicotinamide adenine dinucleotide (NAD+). In the 
presence of target DNA, the rigid DNA double helix 
formed as a result physically removes the cofactor from 
the allosteric site of the enzyme, which down-regulates 
enzyme activity. As such, NAD+ does not get consumed by 
the enzyme which means fluorescence remains on. This 
approach to DNA detection is reported to detect a 50 nM 
concentration of target DNA after a 2 hour reaction time. 
Although no optimisation was performed to try to 
increase the sensitivity of this method, inherent 
drawbacks to this system include a lower affinity of the 
modified flavin towards the enzyme and the weak 
fluorescence of NAD+. 
A similar approach has been demonstrated by Yan et 
al. who use molecular tweezers for enzyme-amplified 
DNA detection (Scheme 26).165 Molecular tweezers are synthetic molecular receptors with two interaction sites bridged by a 
hinged spacer.166 For the detection of DNA, the allosteric site in this example was constructed of single-stranded DNA 
complementary to the target, whilst enzyme and cofactor were attached to either end of the tweezer arms. In the absence of any 
Scheme 24 Mechanical intrasteric enzyme activation for DNA detection. 
Scheme 25 Fluorescent DNA detection via allosteric organic cofactor release and 
consequential down-regulation of enzyme activity. 
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target DNA, the tweezers are closed bringing enzyme 
and cofactor together and activating enzyme activity. 
However, in the presence of target DNA, a rigid double 
helix is formed within the tweezers which prizes enzyme 
and cofactor apart, deactivating enzyme activity. By 
coupling enzyme activity with the production of blue 
dye resazurin 23, which produces a greater signal than 
using NAD+ alone, 0.75 μM target DNA could be 
indicated through the absence of colour production.  
 Metal ion cofactor release has also been exploited for 
allosteric enzyme activation for sensing and has been 
demonstrated effectively by Graf and Krämer for 
fluorescent DNA detection (Scheme 27).167 In the 
presence of Zn2+, single-stranded DNA, complementary 
to that of the target, modified at each end with a 
terpyridine moiety forms a stable cyclic structure.168 
Upon the addition of target single-stranded DNA, a 
conformational change occurs to accommodate the 
formation of the more favourable DNA double helix and 
bis-chelation to the metal ion is disrupted. The inactive 
apoenzyme of carbonic anhydrase (CA) then binds to 
the released metal to form the active holoenzyme. 
Enzyme activity, which indicates the presence of DNA, 
can be detected by the deacetylation of FLDA 18 to give 
the fluorescent product fluorescein 19. Despite this 
elegant approach towards allosteric enzyme activation, 
a significant background reaction by the apoenzyme 
limits the sensitivity of the assay to target DNA 
concentrations of only 0.1 µM. This high background 
reaction observed with CA was considerably reduced by 
replacing the enzyme with a zinc-dependent aldolase 
which, via a signal transduction mechanism, results in 
the consumption of UV-active substrate NAD+, thus developing a switch-off DNA detection method.169 
 Although many enzymes require cofactors, 
releasing them in response to certain analytes 
still remains a substantial challenge. This 
approach towards allosteric enzyme activation 
for signal amplification relies on having a high 
affinity between the cofactor and enzyme as 
well as a low background rate of the 
apoenzyme in the absence of the cofactor. 
However, as shown previously, these criteria 
can be difficult to fulfil. Despite the advantages 
of using enzymes as amplifiers within sensing 
methodologies such as their high turnover 
number, they are expensive, can be difficult to 
manipulate without denaturising and they are 
unable to be used under non-physiological 
conditions. Because of this, synthetic catalysts 
have gained increased interest as amplifiers 
within sensing as they can be easier to 
manipulate, have a higher tolerance to changes 
in conditions and have application to the 
detection of a wider range of analytes. Similarly to enzyme activation, most catalytic signal amplification methodologies use either 
intrasteric or allosteric strategies for controlling catalytic activity.  
Scheme 26 Molecular tweezer approach to colourimetric DNA detection via allosteric 
enzyme activation. 
Scheme 27 Fluorescent DNA detection via allosteric metal ion cofactor release and consequential 
up-regulation of enzyme activity. 
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Intrasteric activation of catalysts for 
sensing involves target recognition at the 
catalyst active site. In principle, catalyst activity 
can be significantly reduced by physically 
blocking the catalyst active site with 
functionalised molecules. If these molecules 
are functionalised with analyte-responsive 
groups, then only in the presence of the 
analyte should the selective removal of the 
catalyst inhibitor occur, which would reveal the 
catalyst active site and restore catalytic 
activity. Simply coupling catalytic activity with 
signal production leads to a successful analyte 
detection assay with catalytic amplification. 
Following their initial publication on the 
allosteric activation of enzymes for DNA 
detection, Krämer et al. adapted the same 
probe, and therefore the same analyte 
recognition procedure, for a synthetic catalyst-
amplified method for DNA detection (Scheme 28).170 Building upon the idea of DNA-templated metal catalysis,171 the authors 
replaced Zn2+ with Cu2+ which, in the absence of the target, still forms the same stable cyclic structure. In the presence of the target 
single-stranded DNA, the formation of the double helix occurs and in the same manner as shown previously, the metal is released 
into the system. An active catalyst is then formed between the released metal and phenanthroline (phen), a ligand capable of 
accelerating copper-catalysed reactions. Non-fluorescent dichlorofluorescein (DCF) 24 is then oxidised by the active Cu·phen 
catalyst to give the fluorescent product dichlorodihydrofluorescein (DCFH) 25. The low turnover rate of the active catalyst however 
limits DNA detection to a concentration of 5 nM.  
 Prins et al. were also able to utilise intrasteric 
regulation of a synthetic catalyst for a 
colourimetric enzyme detection assay (Scheme 
29).172 In this example, gold nanoparticles, covered 
with triazacyclononane (TACN) ligands capable of 
binding Zn2+, were prepared and the resulting 
cationic complexes were shown to effectively 
catalyse transphosphorylation reactions.173 
However, this catalytic activity could be switched 
off through the binding of oligoanions, such as 
peptides, to the catalyst through electrostatic 
interactions, which physically block the active site 
of the catalyst. When the target protease enzyme 
was added, cleavage of the peptides occurred 
which reduces the effectiveness of the binding 
between blocker and nanoparticle. Destabilisation 
reveals the catalyst active sites and catalyses the 
dephosphorylation of substrate 26, which is 
accompanied by the production of yellow reporter 
molecule p-nitrophenol (PNP) 27. The benefits of 
this system include a close to zero background rate, 
a high affinity of the [Zn2+·TACN]2+ complexes 
towards the substrate and a colourimetric 
detection system. Also, the catalyst-amplified enzyme detection assay was shown to be highly sensitive, capable of detecting 
protease subtilisin A at a concentration of 66 nM after an hour reaction time.  
 Intrasteric catalyst regulation through the use of analyte-responsive probe molecules has some inherent difficulties associated 
with it since the catalyst inhibitor requires strong enough binding to prevent a high background reaction but not strong enough to 
prevent an efficient turn on of catalytic activity in response to the analyte. As such, signal amplification by allosteric catalysis (SAAC) 
has by far become the most popular catalytic signal amplification strategy used for sensing.174 Primarily, this is due to the vast 
number of supramolecular receptors used for analyte detection and also the large number of synthetic catalysts used for 
amplification that can be easily coupled together for an amplified detection system.175 Consequently, a significant number of 
Scheme 28 Fluorescent DNA detection via allosteric metal ion release and catalyst activation. 
Scheme 29 Intrasteric activation of a synthetic catalyst for catalyst-amplified colourimetric 
enzyme detection. 
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signalling techniques based upon supramolecular systems have been developed for sensitive DNA, protein and small molecule 
detection.176 Additionally, the binding affinities between different metal‒ligand complexes are well-known allowing for ligand 
exchange to become a prominent analyte detection, and subsequent catalyst activation, mechanism for SAAC. 
Anslyn et al. were the first to exploit ligand 
exchange for SAAC allowing for the detection 
of lead ions (Scheme 30).177 In this approach, 
a Cu2+ complex with 
tetramethylethylenediamine (TMEDA) was 
synthesised and shown to be an inactive 
catalyst within a CuAAC reaction. Metal 
cations, such as Pb2+ and Zn2+, were found to 
competitively coordinate with TMEDA and 
consequently release Cu2+ into the system. In 
the presence of L-ascorbate, Cu2+ is reduced to 
Cu+, the active catalyst within the CuAAC 
reaction. By using FRET pair pyrene-derived 
alkyne 28 and coumarin-based azide 29 as the 
reactants, target metal ion concentration 
could be measured directly by fluorescence 
through the resulting triazole product 30. 
Although being the seminal publication in the 
field, this approach to catalytic signal 
amplification is not without limitations. The 
analyte in question has to have orthogonal 
reactivity to the reaction conditions to not 
cause unwanted side-reactions. For example, Hg2+ was shown not to activate the cycloaddition reaction, but instead oxidised the 
reducing agent. Ligand exchange was also found to be slow, limiting the amount of active catalyst available relative to the 
concentration of analyte. Since the catalytic amplification is a bimolecular reaction, under the dilute assay conditions the reaction 
was deemed incomplete even after 18 hours, which further shows the inefficiencies in this particular catalytic system. Additionally, 
a high concentration of the analyte was found to interfere with the amplification reagents, potentially due to the formation of 
metal acetylides.  
In an ensuing publication,178 the authors sought to overcome 
some of these limitations, by choosing to use a more efficient 
palladium catalyst, as the catalytic signal amplifier (Scheme 31).§ 
The ligand exchange strategy, which allows analyte detection 
through allosteric regulation, was improved by replacing the 
relatively unselective TMEDA ligand with a polyazacyclam (PAC), 
which provided better selectivity for Cu2+ over other metals. Also, 
by designing a catalytic signal amplification methodology around a 
palladium catalyst, an intramolecular Pd0-catalysed Heck reaction 
could be used, which provides increased ease of operation and the 
formation of a fluorescent product.179  
In this strategy, a Pd·PAC complex was synthesised that was 
shown to be inactive towards the Heck reaction. When the metal 
ion analyte is present, in this case Cu2+, ligand exchange occurs 
since Cu2+ has a higher affinity for the PAC than Pd2+, releasing Pd2+ 
into the system which is immediately reduced to the active Pd0 by 
a phosphine ligand. The resulting active catalyst is able to turn non-
fluorescent aryl iodide 31 into fluorescent indole 32 allowing for 
catalyst activity and therefore analyte concentration to be detected via fluorescence. Increasing catalytic activity improved the 
catalytic signal amplification as a detectable fluorescent signal was provided from a 30 nM concentration of Cu2+. Despite this, a 
90 minute reaction time was required and the ligand exchange methodology for analyte detection was shown to be unselective, 
since Ni2+, Co2+ and Cd2+ all delivered false positive results. Better selectivity for the toxic metal ion Cd2+ over Ni2+ and Co2+ could 
be achieved by using a PAC with a bigger ring size to accommodate for the increase in ionic radius.180 Better sensitivity was also 
achieved through the production of a coumarin-derived product since the presence of an electron-withdrawing ester not only 
increases the rate of Heck coupling but the product also has an increased quantum yield than that of indole 32. 
Scheme 30 Allosteric catalyst activation for FRET-based detection of lead ions. 
Scheme 31 Allosteric catalyst activation for the fluorescent detection of 
copper ions. 
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The use of PACs for analyte recognition is a 
major drawback for this methodology since 
analyte detection is limited to only metal ions. 
Also, ligand exchange is slow, reversible and as 
shown previously, unselective. To extend the 
application of this catalytic signal amplification 
methodology beyond the detection of metal 
ions, the group replaced the PAC with a dithiol 
for the fluorescent detection of carbonyl-
containing small organic molecules (Scheme 
32).181 In this approach, target compounds 
containing carbonyl functionality, such as a 
ketone or aldehyde, condense with the 
analyte-recognising dithiol to give a dithiolane, 
which has a considerably lower binding affinity 
towards metals than the free thiol. As a result, 
Pd2+ ions are released into the system and are reduced by phosphine ligands present in the assay mixture, generating the active 
catalyst for a Sonogashira cross-coupling reaction.182 The coupling of phenylacetylene 33 with 9-bromo-10-
(phenylethynyl)anthracene 34 produces the commonly used fluorophore 9,10-bis(phenylethynyl)anthracene (BPEA) 35, therefore 
allowing analyte detection to be easily detected through fluorescence. Despite the catalytic signal amplification, significant 
drawbacks with using the Sonogashira cross-coupling reaction for catalytic signal amplification is its intolerance of water and some 
of the reaction components cause undesired quenching of anthracene fluorescence. However, the initial work published by the 
Anslyn group proved the concept of SAAC and has paved 
the way for this design to be adapted within other signal 
amplification methodologies that utilise allosteric 
control of metal ions for catalyst activation.  
One such methodology was described by Ritter and 
König who developed a signal transduction and signal 
amplification protocol using photo-activated catalysis.183 
In this procedure, a flavin derivative is used as a synthetic 
photoreceptor while the CuAAC reaction is used for 
signal amplification (Scheme 33). Specifically, the 
stimulation of riboflavin tetraacetate 36 by a photon 
gives its strongly-oxidising excited state which, in the 
presence of an electron donor, undergoes 
photoreduction to afford strongly-reducing dihydroflavin 
tetraacetate 37. Dihydroflavin 37 is then capable of 
reducing Cu2+ to Cu+, thus providing the active catalyst 
for the cycloaddition, resulting in the formation of 
triazole 40 from azide 38 and alkyne 39. Signal detection 
was measured through the reduction of observed 
fluorescence since the covalent connection between 
fluorophore and quencher reduces fluorescence 
emission.184 In water, the reaction cascade shows light-
dependent behaviour as only under irradiation is 
significant fluorescence quenching observed. When 
irradiation is stopped, disproportionation of Cu+ to Cu0 
and Cu2+ occurs, which removes the active catalyst from 
the system and stopping the cycloaddition reaction. 
However, it was found that excess continuous irradiation 
leads to the formation of undesired by-products. Other 
problems associated with the assay include requiring 
oxygen-free conditions to prevent formation of flavin 
hydroperoxides and a slow background reaction in the 
absence of light due to spontaneous reduction of Cu2+ to 
Cu+ by triethylamine in solution. However, the principle 
of transforming a non-chemical input signal, in this case 
Scheme 32 Allosteric catalyst activation for the fluorescent detection of small, carbonyl-
containing organic molecules. 
Scheme 33 Light-activated catalytic signal amplification. 
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light, into an amplified chemical output signal is superbly illustrated in this example, inspiring other groups to develop similar signal 
transduction and amplification chemical systems.  
The majority of examples of allosteric catalyst activation previously described have been based upon metal‒ligand binding 
affinities where, analyte recognition leads to coordination disruption followed by metal ion release and consequent active catalyst 
formation. However, this is an imperfect approach since analyte recognition is a reversible reaction between the analyte and the 
active catalyst responsible for signal amplification. Also, the formation of the active catalyst is not necessarily instantaneous after 
analyte recognition which leads to long assay times. To overcome these problems, Mirkin et al. have developed synthetic enzyme 
mimics based upon supramolecular coordination chemistry.185 
To achieve this, inorganic macrocycles were constructed via the weak-link approach (WLA) consisting of two metal centres and 
two hemilabile ligands.186 The ligands are the key to this concept as they are polydentate chelates containing two sets of two 
differently coordinating heteroatoms; one set that strongly binds to the metal centre and one set that weakly binds to the metal 
centre. The dimer that initially forms has all coordinating atoms bound to a metal centre and in this ‘closed’ structural 
conformation, the ligand spacers are forced together. The introduction of small, coordinating molecules, that have a higher affinity 
to the metal than the weakest metal‒heteroatom bond, displace the weakly binding heteroatom of the ligand. This then causes a 
structural conformational change to give an ‘open’ complex since the ligand spacers are now pulled apart. This precise control over 
the structural conformation of a macrocycle led to the subsequent development of a synthetic supramolecular catalyst where 
catalyst activity could be regulated 
allosterically.187 
To obtain catalytic activity selectively as a 
result of a structural change in conformation, 
the ligand spacers were replaced with a 
[Cr·salen]3+ complex proven to catalyse epoxide 
ring-opening reactions.188 In the absence of the 
small molecule effectors, the tetrametallic 
supramolecular construct was shown to be in 
its ‘closed’ conformation and exhibited minimal 
catalytic activity towards the ring-opening of 
cyclohexene oxide since the catalyst active sites 
are pushed too close together and thus 
blocking one another, preventing the substrate 
from reaching the catalyst active site. The 
addition of small molecule effectors Cl‒ and CO 
result in them binding to the allosteric Rh+ 
metal centre and causing a structural change in 
the macrocycle to its ‘open’ conformer, known 
as halide-induced ligand rearrangement 
(HILR).189 The Cr3+ metal centres are then pulled 
apart from one another revealing the active 
sites for the substrate, which consequently 
leads to a 25-fold increase in catalytic activity. 
In addition, the bimetallic active site of the 
supramolecular catalyst was shown to have an 
increased rate of reaction over its monomeric 
counterpart, which explains the low 
background rate observed when the catalyst is 
‘closed’.190 Since the epoxide ring-opening 
reaction is not attributed with a change in physical property, signal amplification via this approach to allosterically-regulated 
supramolecular catalysis could not be used for sensing purposes. 
Towards this end however, the group sought to change the catalyst responsible for signal amplification to a [Zn·salen]2+ 
complex capable of catalysing the acylation of 4-pyridyl carbinol 41 (Scheme 34).191 As a consequence of the acylation, the pH of 
the reaction medium is lowered since acetic acid is formed as a by-product and as such, signal production was achieved through a 
pH-responsive fluorophore 45 allowing for analyte detection to be determined using fluorescence.192 Under an atmosphere of 
carbon monoxide, an 800 nM concentration of Cl‒ ions could be distinguished from the background reaction after 6 hours. Since 
the supramolecular catalyst is modular by design, alternative metals can be used at the allosteric site of the supramolecular catalyst 
yet still maintain the same mode of activation and the same catalytic reaction for amplification. This can therefore expand the 
application of the signal amplification procedure towards the detection of different analytes.193 It is thought that increased control 
and a reduction in background catalytic activity could be achieved through a triple-layer catalyst where the middle layer holds the 
Scheme 34 Allosteric regulation of a supramolecular catalyst for catalytic signal amplification.  
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active catalyst and the top and bottom layers physically block the catalyst active sites when the supramolecular structure is 
‘closed’.194 Currently, the addition of the small molecule allosteric effectors can induce a structural change in the supramolecular 
structure to its ‘open’ conformer and restore catalytic activity to polymerise ε-caprolactone,195 but has yet to be applied towards 
a sensing methodology. 
 
Double-Catalyst Signal Amplification 
In principle, the addition of an extra catalytic cycle 
to a single-catalyst signal amplification procedure 
should accelerate the rate of signal production 
over time and in turn, would lead to a signal 
increase orders of magnitude higher than that of 
just doubling the number of catalysts of a single-
catalyst system. However, in comparison to the 
number of single-catalyst signal amplification 
procedures described, the use of two 
sequentially-activated catalysts for signal 
amplification is a considerably less explored area. 
This could be, in part, due to the difficulty in 
finding catalyst combinations whereby products 
resulting from the first catalytic cycle are able to 
act as catalyst activators for the second catalytic 
cycle. In addition, to afford sufficient assay 
sensitivity, the background reaction of the second 
catalyst must be minimal, if not zero, to minimise 
false positive results. Initially, signal amplification 
protocols utilising a two catalyst cascade were 
developed as a result of applying a single catalytic 
amplification procedure towards the detection of 
a target that itself also displays catalytic activity.  
The first example of a double catalyst signal 
amplification strategy for a sensing application 
was demonstrated by Zuchner et al. for protease detection using FRET (Scheme 35).196 Sensitive protease detection is of 
paramount importance as abnormal protease activity has been associated with a variety of diseases, one of which includes 
cancer.197 As such, there has been huge demand for the development of highly sensitive protease assays and methods to achieve 
high sensitivity have been through the use of enzyme cascades for signal amplification.198 
 In this particular example, an initial optimisation of a FRET-based detection assay was performed on trypsin, a digestive enzyme 
that selectively cleaves peptides at the carboxyl side of amino acids lysine or arginine.199 Of the trypsin substrates synthesised and 
tested, peptide 47 was found to be optimal as it showed a >97% quenching efficiency in the absence of the enzyme and after 
trypsin was introduced, maximum fluorescence was obtained in 15 minutes, achieving a LOD of 0.1 fmol. With the second catalytic 
cycle of the amplification methodology optimised, the next objective was to selectively activate it. 
 To do this, the group chose serine protease enteropeptidase, the intestinal enzyme responsible for activating multiple digestive 
enzymes in response to food ingestion,200 and whose congenital deficiency can lead to severe intestinal malabsorption.201 Its 
primary mode of action is to catalyse the activation of trypsin from the inactive zymogen, trypsinogen.202 As such, trypsin was 
replaced with trypsinogen and exposed to enteropeptidase to determine if the enteropeptidase could catalyse the activation of 
the second catalytic signal amplification. Indeed, in the presence of enteropeptidase, a fluorescent signal was obtained which was 
attributed to the in situ conversion of trypsinogen to trypsin and consequent consumption of pro-fluorescent substrate 47. This 
double-catalytic signal amplification methodology achieved a LOD of 0.01 fmol for enteropeptidase after an assay time of 3 hours 
and demonstrated an excellent dynamic range showing a linear signal‒concentration correlation over two orders of magnitude. 
 The high sensitivity and selectivity obtained for this dual-enzyme signal amplification approach has inspired others to do the 
same by developing inactive zymogens as enzyme precursors that can be activated by a clinically-relevant enzyme to produce a 
detectable signal. One such example can be provided by Yoo et al. who engineered β-lactamase zymogens for amplification and 
determination of protease activity (Scheme 36).203 In this approach, an inactive β-lactamase zymogen was constructed using 
intrasteric inhibitor BLIP attached to the enzyme through a peptide linkage. In the presence of the protease, the peptide linkage is 
cleaved and intrasteric activation of β-lactamase occurs as BLIP is removed from the active site. β-Lactamase activity, and therefore 
protease activity, was measured by the change in absorbance from β-lactamase substrate, 7-(2-thienylacetamido)-3-((3-carboxy-
4-nitrophenyl)thiomethyl)-cephalosporonic acid (CENTA) 50 to hydrolysed product 51.204 To prevent the BLIP from remaining 
Scheme 35 Double-catalyst signal amplification approach to the FRET-based detection of 
enteropeptidase. 
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 23  
Please do not adjust margins 
Please do not adjust margins 
bound to the β-lactamase after protease-
catalysed amide hydrolysis, which would 
reduce the potential positive output signal, 
a number of β-lactamase mutants were 
synthesised and tested within the assay. 
Through this optimisation, a β-lactamase 
mutant with a lower binding affinity to BLIP 
was able to deliver a 68-fold signal increase 
from the background reaction. This mutant 
was then utilised as the signal-amplifying 
enzyme within a dual-enzyme signal 
amplification strategy for the detection of 
matrix metalloproteinase-2 (MMP2), a 
protease that plays a significant role within 
cancer progression,205 and was shown to 
be detectable at concentrations down to 
25 pM.  
 Another approach to enzyme-triggered 
enzyme activation has been through the 
use of split-protein systems. Split proteins 
are two protein fragments that do not 
exhibit any catalytic activity separately but 
can come together to form an active 
enzyme.206 By physically preventing the split-proteins from coming together through an enzyme-cleavable intrasteric inhibitor, an 
enzyme-amplified enzyme detection assay can be achieved. This tactic was exemplified by Ghosh et al. who utilised the split-
protein system of the enzyme firefly luciferase (FLuc) for protease detection (Scheme 37).207 To prevent the split-proteins from 
coming together, one of the split-proteins was appended with a structure comprised of two interlocking α-helices known as a 
coiled-coil.208–209 In the presence of the target protease, the peptide linkage between the protein and the coiled-coil is cleaved 
allowing the two protein halves to reassemble to form the active FLuc. Once activated, FLuc is able to catalyse the bioluminescent 
oxygenation of 52, allowing protease activity to be determined via luminescence. Through this dual-enzyme amplification cascade, 
a 1000-fold increase in the signal-to-noise ratio could be obtained for the detection of tobacco etch virus (TEV) protease. The 
modularity of this method has allowed other split-protein type enzymes, such as β-lactamase, to be used as the enzyme amplifier 
and this signal amplification method has also been applied to the detection of caspases by simply changing the enzyme-cleavable 
linkage between the coiled-coil and the split-protein.210 
 Utilising enzyme cascades for signal 
amplification relies on the ability to structurally 
modify enzymes to restrict enzyme activity 
without denaturisation yet in the presence of the 
target, enzyme activity must be easily restored. 
Although a number of examples have been 
demonstrated, this still remains a significant 
challenge. A way of incorporating enzyme 
cascades for signal amplification without 
needing structural modification of enzymes is to 
use solid-supported enzyme substrates, as 
enzyme activity can be introduced and removed 
through physical addition and aspiration steps. 
Inspired by assays where catalyst activity can be 
measured through immunoassays,211–212 Garner 
and Janda developed a catalytic assay using an 
enzyme-linked click-chemistry assay (cat-ELCCA) 
for the fluorescent detection of ghrelin O-
acyltransferase (GOAT) (Scheme 38).213 In this 
approach, a biotin-labelled peptide enzyme 
substrate is captured on a streptavidin-coated 
solid surface. In the presence of the target 
enzyme, a selective O-acyl transfer occurs where 
Scheme 36 Double-catalyst signal amplification for an absorbance-based protease detection assay. 
Scheme 37 Double-catalyst signal amplification for a bioluminescent protease detection assay.  
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a serine residue is esterified with an n-
octynoyl group. The resulting alkynylated 
product is then labelled with HRP via a click 
reaction, which is able to provide signal 
amplification through catalytic production 
of fluorescent compound resorufin 14 from 
HRP-substrate amplex red 47. Through this 
unique double-enzyme signal amplification 
approach, a greater than 7-fold fluorescence 
enhancement was observed. Since GOAT is 
involved in the acylation of the gastric 
peptide hormone ghrelin,214 this signal 
amplification methodology was 
subsequently used in the discovery of 
potent GOAT inhibitors as promising anti-
obesity and anti-diabetes drug targets.215  
 However, double catalyst signal 
amplification is not just limited to the use of 
enzymes for amplification. Until quite 
recently, the successful application of a 
double-catalyst signal amplification 
approach towards sensing had only been 
achieved through a dual enzyme strategy. A 
methodology that utilised a hybrid enzyme–
catalyst approach was first described by 
Tang et al., for the ultrasensitive 
colourimetric detection of PSA (Scheme 
39).216 
In this example, a typical sandwich ELISA was constructed, designed for the detection of PSA, using ALP as the enzyme label. In 
the presence of the enzyme, and therefore the target, ALP substrate L-ascorbic acid 2-phosphate (AA2P) 55 becomes hydrolysed 
to ascorbic acid (AA) 56. AA was then able to reduce a palladate species to the active catalytic palladium nanostructures that 
aggregate upon the surface of non-participating gold nanoparticles.217 As a peroxidase mimic, the palladium nanostructures can 
catalyse the hydrogen peroxide-mediated oxidation of 3,3’,5,5’-tetramethylbenzidene (TMB) 58 to its corresponding blue diimine 
59.218 Through an extensive screening process, a positive colourimetric signal was shown to only be produced by the palladium 
nano-catalysts which themselves 
were only created in the presence of 
ALP, consequently leading to a low 
background signal. Importantly, the 
double-catalyst signal amplification 
procedure was shown to be 
significantly more sensitive than a 
traditional single-catalyst ELISA and 
could deliver an LOD of 0.05 ngmL−1 
for the detection of PSA. However, 
due to the number of reagents 
required to acquire a positive signal, 
the procedure is considerably labour-
intensive and requires the time-
consuming preparation of gold 
nanoparticles.  
Shortly thereafter, Frost et al. 
disclosed another hybrid enzyme–
catalyst double catalyst signal 
amplification methodology aimed at 
the detection of ALP (Scheme 40).219 
Rather than utilising enzyme-
catalysed metal nanoparticle 
Scheme 38 Catalytic assay using enzyme-linked click-chemistry assay (cat-ELCCA) for the fluorescent 
detection of ghrelin O-acyltransferase (GOAT). 
Scheme 39 Double-catalyst signal amplification protocol for the colourimetric detection of PSA.  
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formation for catalytic amplification, enzyme-
triggered ligand release and subsequent ligand-
accelerated metal catalysis was employed.220 In 
this approach, enzyme substrate 60, termed a 
proligand, was designed with an enzyme-
responsive trigger, a self-immolative spacer and 
a diamine ligand. In the presence of the target 
enzyme, enzyme-catalysed cleavage of the 
trigger occurs to afford phenolate 61 which is 
unstable under the basic conditions of the assay 
and undergoes 1,6-elimination followed by 
decarboxylation to release ligand 62. Once 
released, the ligand is capable of binding to an 
iridium pre-catalyst to generate active catalyst 
63, a very efficient organometallic complex 
within catalytic transfer hydrogenation 
reactions.221 Consequently, 
ferrocenecarboxaldehyde 64 is reduced by the 
iridium catalyst to afford ferrocenemethanol 65, 
both of which can be distinguished 
electrochemically. As a result of the powerful 
dual catalysis, a LOD of 7.6 pM concentration 
could be achieved after a 3 minute assay time. 
The sensitivity was compromised however due 
to an undesired background reaction caused by 
the iridium precatalyst. The protocol did exhibit 
excellent versatility as it was applied to a range 
of aldehyde catalyst substrates, easily allowing 
for alternate signal readout methods to be 
chosen if required.  
Deoxyribozymes can be used as alternatives 
to synthetic catalysts within a catalytic signal amplification methodology as demonstrated by Mao et al. who utilised a double 
catalyst signal amplification methodology for colourimetric DNA detection (Scheme 41).222 Deoxyribozymes, also known as DNA 
enzymes or DNAzymes, are catalytic domains comprised of DNA rather than amino acids and are therefore considered to be more 
stable than traditional protein-based enzymes.223 In this amplification approach, target DNA is detected using a complementary 
DNA probe that is also a circular template for 
RCA, which codes for the linear production of 
DNAzymes. Therefore, the target DNA acts as 
a primer for RCA and once hybridised, 
initiates the production of repeating units of 
DNA that form multiple DNA peroxidases 
after complexation to hemin. The DNA 
peroxidases can then catalyse the oxidation 
of 2,2’-azino-bis(3-ethylbenzothiazoline-6-
sulfonic acid) (ABTS) 66 to afford 
colourimetric product 67. This procedure 
showed an excellent dynamic range where 
DNA detection covers concentrations over 
four orders of magnitude and delivered a 
LOD of 1 pM. However, problems associated 
with using RCA as the initial amplification 
procedure include strict amplification 
durations as any reaction time longer than 
optimal, results in extensive tangling of the 
DNAzyme chains. Not only this, but the 
concentration of the circular RCA template is 
also important as a high enough 
Scheme 40 Double-catalyst signal amplification protocol for the ratiometric electrochemical 
detection of ALP. 
Scheme 41 Rolling circle amplification and DNAzyme catalytic cascade for colourimetric DNA 
detection. 
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concentration is required to ensure efficient binding to the target, yet too high a concentration leads to unwanted binding of the 
template to the amplified DNA product thus preventing further amplification and folding of the DNA into the DNAzyme. A similar 
DNAzyme cascade has since been described by Tan et al. that replaces RCA with an alternative DNAzyme to deliver a double-
catalyst signal amplification strategy for colourimetric protein detection.224  
A similar strategy has been described by Aoyama et al. who use ribosomal catalytic production, or translation, of protein-based 
enzymes for the double-catalytic chemiluminescent detection of human immunodeficiency virus (HIV) RNA.225 For successful RNA 
detection, the group utilise the molecular beacon approach,226 where in the absence of the target, the RNA probe intramolecularly 
binds to itself to adopt a hairpin-like conformation which cannot activate the catalytic amplification cascade. When in the presence 
of the target oligodeoxynucleotide (ODN), the resulting double-stranded duplex prevents the probe from adopting the hairpin-like 
conformation from occurring, thus revealing the riboregulator which is the specific sequence of the probe that activates 
translation. Once activated, the catalytic production of luciferase enzymes begins which are able to produce a chemiluminescent 
output signal. By using the molecular beacon probe, excellent selectivity was achieved and due to the double-catalyst signal 
amplification, good sensitivity was also obtained with a target ODN concentration of 50 fmol being detectable. However, because 
of the size of the target‒probe duplex in 
comparison to the riboregulator sequence, 
inefficient allosteric activation of the 
transcription enzyme was observed, leading 
to a loss in sensitivity. 
To address this, the group combined their 
double-catalyst signal amplification 
methodology with EATR to create a triple-
catalyst cascade (Scheme 42).227 In this 
advancement, the duplex formed as a result 
of target‒probe hybridisation is cleaved by a 
ribonuclease which not only releases the 
riboregulator, thus making allosteric 
activation irreversible, but also recycles the 
target ODN. This both improves allosteric 
translation enzyme activation and allows the 
target ODN to react further with more 
probes. The extra catalytic cycle of the 
amplification cascade enhances both 
sensitivity and selectivity, obtaining a target 
ODN concentration LOD of 9 fmol. In 
addition, the riboregulator sequence can be 
altered to activate catalytic production of β-
gal enzymes which enables the visible 
detection of nucleic acid sequences through 
conversion of o-nitrophenol-β-D-
galactopyranoside (ONPG) 68 to o-
nitrophenol (ONP) 69.  
 The majority of double-catalyst signal 
amplification methodologies described to 
date involve the manipulation of enzyme 
cascades rather than the use of synthetic 
catalysis. This is primarily due to the well-
known number and variety of enzyme cascades used in nature for a number of purposes. This leads to the easy transition from 
biosignalling to signal amplification within a sensing methodology by coupling the final enzyme with a colour or fluorescent 
production. Although selectivities and sensitivities are high, adjusting enzyme cascades towards the signal amplification of 
different analytes, especially when detection is required in non-aqueous solvents, can be difficult. As such, there is still demand 
for the easily-adaptable synthetic double-catalyst cascades for the sensitive detection of small organic molecules. Furthermore, 
the recent development of hybrid systems that utilise the efficiency of enzymes under physiological conditions along with the 
control and robustness offered by synthetic catalysts demonstrates both good sensitivity as well as excellent versatility within 
sensing applications.  
Scheme 42 Double-catalyst amplification cascade combined with EATR to obtain a triple-catalyst 
cascade for the visible detection of nucleic acids. 
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 27  
Please do not adjust margins 
Please do not adjust margins 
Autoinductive Signal Amplification 
Autoinduction is the process whereby the reactants 
or products of a reaction can directly or indirectly 
affect the rate of the reaction, whether it is either in 
a positive or negative way. This process is typically 
associated with metabolic enzymes in the body 
whereby an active pharmaceutical ingredient (API) 
can induce or up-regulate an enzyme involved in its 
own metabolism.228 By designing a system whereby 
the products of a reaction can induce or up-regulate 
the rate of its own production, then this would 
provide significant signal amplification if applied to a 
sensing methodology. Towards this end, Sella and 
Shabat designed the concept of the dendritic chain 
reaction (DCR) (Scheme 43).229 
Dendrimers themselves are uniform molecular 
trees made up of highly-branched, repeating units, 
often with reactive functionality on the end groups, 
which are attached to a central core.230 Because of 
their unique supra- and macromolecular properties, 
dendrimers have found application within multiple 
fields such as medicine, catalysis and in particular, 
sensing.231 The concept of constructing dendrimers 
comprised of repeating units capable of undergoing 
elimination mechanisms initially allowed dendrimers 
to be shown to selectively release their cargo in response 
to a specific stimulus such as, drug compounds under 
reductive conditions,232 coloured compounds when 
exposed to palladium,233 and fluorescent compounds in 
response to light.234 The spontaneous disassembly, or 
self-immolation, of dendrimers in response to a specific 
stimulus has provided a distinctive molecular 
amplification approach to sensing since one analyte can 
trigger the disassembly of a dendrimer with multiple 
reporter end groups.235 However, dendritic amplification 
only multiplies the initial input molecule by the number 
of end-groups attached to the dendrimer core. For 
example, in a sensing methodology for the detection of 
the explosive triacetone triperoxide, a dendrimer with 
three reporter molecules was shown to provide three 
times the signal compared with a non-dendritic 
reporter.236 In order to provide amplification more akin to 
a catalyst or an enzyme in which signal amplification 
increases over time, DCR was designed to take advantage 
of the multivalent capabilities of dendrimers by attaching signal transducers as well as reporter molecules to the central core. Once 
released, the signal transducers could be manipulated into inducing further dendrimer disassembly, therefore leading to an 
autoinductive signal amplification mechanism being in effect. 
 The successful achievement of an autoinductive signal amplification methodology through the use of dendrimers was through 
the clever design of dendron 70, which consists of a p-nitroaniline reporter molecule, two molecules of choline to relay the signal 
and a phenylboronic acid used for analyte recognition (Figure 4). In the presence of hydrogen peroxide, aryl boronic acids are 
known to undergo oxidation to their corresponding phenolates,237 via a Baeyer‒Villiger-type mechanism,238 analogous to the Dakin 
oxidation.239 This functional group transformation had previously been exploited for the fluorescent stoichiometric detection of 
hydrogen peroxide.240  
 In DCR, phenolate 71 produced as a result of the oxidation is unstable under the mild alkaline assay conditions and undergoes 
multiple quinone methide eliminations,241 followed by entropically-favourable decarboxylation to release colourimetric reporter 
72 and two equivalents of choline 74 to propagate the signal (Scheme 44). This is performed by the enzyme choline oxidase (COx), 
Scheme 43 Amplification concept of the dendritic chain reaction (DCR). 
Figure 4 Structure of dendron 70; responsive to target, and signal propagating 
molecule, hydrogen peroxide. 
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which twice oxidises choline to afford 
trimethylglycine 77 and in the process, 
generates two equivalents of hydrogen 
peroxide capable of initialising the 
breakdown of more molecules of dendrons 
70 (Scheme 45). The requirement of COx for 
signal propagation is especially apparent at 
low concentrations of hydrogen peroxide, 
as a >50-fold signal enhancement is 
observed in comparison to a system without 
COx. The exponential production of 
hydrogen peroxide and subsequent 
exponential decay of all dendrons 70 leads 
to rapid signal production with full 
conversion observed after 50 minutes. The 
DCR was then applied to the colourimetric 
detection of penicillin-G-amidase (PGA), 
through the use of a choline-releasing 
probe, and showed a significant signal 
increase in comparison to a classic probe-
based approach, allowing for PGA 
concentrations of 0.1 µgmL−1 to be 
detected.  
One of the major benefits of using DCR as a 
signal amplification technique is its 
modularity. For example, by changing the 
boronic acid trigger with a silyl-protected 
phenol enables an autoinductive exponential signal amplification procedure for the sensitive detection of fluoride ions.242 
Additionally, the enzyme amplifier could be replaced with other enzymes capable of producing hydrogen peroxide, such as alcohol 
oxidase (AOx).243 Despite its wide application, a major weakness of DCR, like many exponential signal amplification methodologies, 
is the high background rate observed in the absence of the trigger, which arises from undesired hydrolytic cleavage of the 
carbonate linkages.244 Another difficulty lies in the synthesis of the dendrimers as a large number of challenging synthetic steps 
that are often required to successfully obtain them.  
 To address these issues, the group developed a two-component dendritic chain reaction (2CDCR) where one reagent 77 
contains the trigger unit responsible for analyte detection and signal transduction while the second reagent 79 was solely 
responsible for signal production (Scheme 46).245 Through this two-component methodology, the unwanted background signal 
was suppressed as hydrolysis of 77 does not directly lead to signal production. Also, by separating analyte detection and signal 
production into different compounds, a mix-and-match approach to sensing can be applied to allow DCR signal amplification to be 
applied to a fluorescence detection assay. Alternative enzyme amplifiers have also been incorporated into 2CDCR as a number of 
glucose-containing dendritic amplifier components were tested using glucose oxidase (GOx) as the enzyme amplifier.246 
Additionally, the use of a quinone-based detection component allowed for the 2CDCR to be applied to the detection of thiols.247 
Autoinductive signal amplification can also be achieved in the absence of 
the enzyme amplifier by utilising the hydroquinone–quinone oxidation 
by molecular oxygen as a method for generating hydrogen peroxide in 
situ without the need for additional biological components.248–249 
 An example of a two-component autoinductive signal amplification 
protocol used in combination with target amplification for increased 
sensitivity was described by Baker and Phillips for the colourimetric 
detection of palladium (Scheme 47).250 To achieve this autoinductive 
signal amplification methodology, the first component 81 of the two was 
equipped with an allyl carbamate trigger, for selective palladium 
detection, and two fluoride leaving groups as the amplified signal relay. 
In the presence of palladium therefore, catalytic deallylation and 
decarboxylation occurs to give 4-(difluoromethyl)aniline which 
undergoes a double 1,6-elimination to produce two fluoride ions. The 
second component 82, a colourimetric probe for fluoride detection 
itself,251 was equipped with a silyl protecting group, sensitive to the 
Scheme 44 Breakdown mechanism of dendron 70 initiated by hydrogen peroxide.  
Scheme 45 Signal propagation in DCR: enzyme-catalysed 
hydrogen peroxide formation. 
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fluoride relay signal, along with another two equivalents of fluoride to further amplify the signal. After initial breakdown of 81 in 
response to the analyte, silyl deprotection of 82 occurs due to the generated fluoride and intermediate phenolate 83 also 
undergoes a 1,6-elimination and decarboxylation to afford another equivalent of aniline 84, capable of eliminating further to afford 
another two equivalents of fluoride. Colourimetric detection occurs following elimination of 84 as the compound 4-
aminobenzaldehyde 85 produced as the elimination by-product is yellow. This two-component autoinductive signal amplification 
strategy in combination with an analyte that exhibits target catalysis allows for a LOD of 0.36 ppm palladium, a concentration of 
palladium typically found in roadside dust.252  
 The reagents used to within this assay are thermally-stable and inexpensive and the colour produced can be seen with the 
naked eye enabling this methodology to be used in resource-limited environments. However, reaction times are slow with >24 
hour assay times required to detect palladium concentrations close to the LOD. Also, due to the slow hydrolysis of 82, an amplified 
background reaction limits assay sensitivity, although the introduction of allylic ethers as elimination linkers have shown promise 
in minimising background reactions yet maintaining signal propogation.253 The modularity of the small molecule autoinductive 
signal amplification approach has enabled an extension of compound 82 to be developed for fluorescent fluoride detection.254 
Scheme 46 Two-component dendritic chain reaction (2CDCR). 
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 The ability of a signal amplification protocol to generate products that not only provides a detectable signal but can also 
increase the rate at which the signal is produced, has allowed previously inaccessible detection limits to be achieved. Inspired by 
DCR, the majority of autoinductive signal amplification approaches currently described revolve around small molecule-based 
systems which allow for thermally-stable, inexpensive reagents to be used for analyte detection, signal amplification and signal 
production in a simple manner. Current challenges involve improving reaction times to allow for these signal amplification 
methodologies to be applied within the POC setting. In addition, suppression of the high background rates associated with 
spontaneous hydrolysis of these reagents should allow for better detection limits to be obtained. 
 
Autocatalytic Signal Amplification 
Autocatalysis is the process whereby the product of a reaction is able to catalyse the production of itself.255 This fascinating 
phenomenon has been intensively studied for the past forty years since autocatalysis may have played a significant role in the 
origins of life.256–257 Autocatalytic mechanisms can vary considerably from templated self-replication and physical reproduction 
processes to asymmetric autocatalysis.258 Early synthetic examples of autocatalysis involved the self-replication of small 
oligonucleotides where the product can act as a template, assisting the formation of more oligonucleotides.259–261 Synthetic 
template-assisted autocatalysis,262–263 has also been applied to the self-replication of peptides,264 as well as small molecules.265 
Metal-catalysed autocatalysis was first described by Soai et al. where the alcohol formed as the product was able to act as a ligand 
within a zinc-catalysed alkyl addition to aldehydes, promoting the formation of more of itself.266 Since the reaction can be 
performed asymmetrically, this reaction can be applied to selectively amplify one enantiomer over another and therefore increase 
the enantiometric excess of a near racemic mixture.267–270 This powerful asymmetric amplification method has even been used to 
discriminate between carbon-12/carbon-13  chirality,271 which has huge implications for determining the origins of 
homochirality.272–273  
 Although considerable effort has been made towards enantioselective amplification using autocatalysis,274 the application of 
autocatalysis towards a signal amplification methodology has been comparatively less explored. To date, only two autocatalytic 
Scheme 47 Two-component small molecule autoinductive signal amplification for colourimetric palladium detection.  
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signal amplification methodologies for sensing have been published and both are advancements upon signal amplification 
concepts already described herein. The first of the two was developed by Yoon and Mirkin who manipulated their supramolecular 
catalysts to be activated by the product allowing for autocatalytic signal amplification to be applied towards the fluorescent 
detection of acetate anions (Scheme 48).275 
 In a previous example, supramolecular constructs based upon the WLA were shown to rearrange selectively in the presence of 
the chloride analyte to reveal a bimetallic active site for a Lewis acid-catalysed acylation reaction. Since the by-product of this 
acylation is acetic acid, the authors hypothesised that an autocatalytic variant of SAAC could be achievable if the produced acetate 
anion could bind to the allosteric site of the pre-catalyst and also induce ligand rearrangement. Thus, in the presence of 
tetrabutylammonium acetate (TBAA), used as the model analyte, and under a carbon monoxide atmosphere, catalytic activity was 
shown to be switched on through the production of fluorescence. Initially, a minor amount of the catalysts are activated leading 
to slow product formation. However, as more acetate is produced, an increase in catalyst activation is observed leading to an 
acceleration of catalytic activity until the reaction reaches its saturation point when full consumption of the substrate occurs. This 
is confirmed by a study of the reaction kinetics; the conversion–time graphs display sigmoidal curves characteristic of autocatalytic 
product generation which starts with a slow induction period followed by an exponential increase before reaching a plateau.276 
Similarly to PCR, analyte concentration correlates with the time taken to reach exponential signal amplification. Importantly for 
autocatalytic signal amplification protocols, almost no conversion was observed in the absence of acetate. Although variations at 
the allosteric site of the catalyst amplifier and the use of alternative pH-responsive reporters for different readouts would allow 
this autocatalytic signal amplification protocol to be used within multiple applications, the current procedure described appears 
to be limited towards only acetate detection.  
 A more flexible approach to autocatalytic signal amplification was provided by Phillips et al., who described an autocatalytic 
variant of their two-component autoinductive signal amplification procedure for colourimetric palladium detection (Scheme 49).277 
To achieve autocatalysis, signal amplification reagent 89 was designed, inspired by amine proliferation compounds used within 
photolithography,278 with a 9-fluorenylmethoxycarbonyl (Fmoc) reporter moiety and a piperidine unit connected via an aniline 
linker. Analyte-responsive reagent 87 was equipped with an allyl carbamate trigger for selective palladium detection adjoined with 
a signal propagating piperidine group via an electron-rich aniline, which facilitates elimination upon analyte recognition.279 In the 
presence of palladium, deallylation and elimination of 89 occurs releasing the piperidine catalyst. Since palladium also exhibits 
target catalysis, multiple equivalents of piperidine can be released per molecule of palladium thereby increasing assay sensitivity. 
After release, piperidine acts as a catalytic base, deprotonating 89 to release another equivalent of piperidine and the 
dibenzofulvene chromophore 90. Proton transfer then occurs regenerating the original catalytic base and creating another 
catalyst. This cycle repeats until full consumption of signal amplification reagent 89 occurs and full conversion is obtained.  
Scheme 48 Supramolecular autocatalytic signal amplification for fluorescent acetate detection. 
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 A piperidine catalytic loading of 0.1 mol% was shown to initiate full breakdown of 89 over 18 hours and exhibited a sigmoidal 
reaction profile over this time period which indicates that an autocatalytic mechanism was in effect. This two-component small 
molecule approach to autocatalytic signal amplification was capable of reaching a LOD of 12 ppm for palladium and variations of 
2 ppm in palladium concentration could be easily distinguished. Despite >1000-fold signal amplification, the long induction time 
required for low analyte concentrations prevents this methodology from being employed for POC diagnostics. However, this 
methodology could see use within areas such as stimuli-responsive materials where high amplification is required but a specific 
timeframe in which this occurs is less important.280 
Autocatalytic signal amplification has the potential to fulfil the needs of diagnostic assays which suffer from a lack of sensitivity 
and is capable of detecting analyte concentrations unreachable by other signal amplification methods. The development of such 
protocols is still in its infancy with only two examples successfully demonstrated to date. They have however, shown that 
autocatalytic signal amplification is achievable through completely different methods and should inspire the next influx of 
amplification approaches to match, if not better, current detection limits. Future efforts should also be aimed at providing 
autocatalytic signal amplification towards detection of biological samples allowing them to be incorporated within medical 
diagnostic applications. Furthermore, the time taken to induce exponential amplification should be dramatically shortened to 
enable autocatalytic signal amplification to be applied at the POC setting. 
Receptor Amplification 
Within a detection assay, signal production typically occurs after the result of an analyte‒probe recognition event. Increasing the 
number of analyte receptors upon the probe would therefore lead to an increase in the probability of an analyte‒probe recognition 
event occurring and therefore faster signal production. This concept is perfectly exemplified by Amir and Shabat who were able to 
  
Scheme 49 Small molecule autocatalytic signal amplification for colourimetric palladium detection.  
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increase the number of analyte-responsive 
triggers on a dendrimer in order to achieve an 
amplified signal response (Figure 5).281 In this 
example, three dendrimer derivatives were 
synthesised containing one, two or four enzyme 
responsive triggers connected to a single 
reporter molecule. Since the removal of just a 
single trigger is capable of releasing the reporter 
molecule, the dendrimer with the most receptors 
should deliver the fastest response. Indeed, in 
the presence of the enzyme target, dendrimer 93 
with two enzyme triggers was shown to eliminate 
twice as fast as dendrimer 92 containing only one 
enzyme trigger. However, due to slow 
elimination kinetics associated with the 
increased number of eliminations required, 
dendrimer 94 with four enzyme triggers attached 
to the reporter molecule was actually shown to 
produce a considerably slower signal. Still, this 
dendritic approach to receptor amplification was 
successfully coupled to a dendritic signal 
amplifier to significantly reduce the time-to-
result yet still provide an amplified signal for the 
detection of PGA.282 It is on this basic principle 
that the majority of receptor amplification 
methodologies are based upon. 
Similarly, but conceptually opposite, to label 
amplification, receptor amplification 
methodologies utilise the multivalent 
characteristics of a range of molecular structures to sufficiently amplify the number of receptors adjoined to the signal producer. 
This has allowed structures such as polymers, micelles and hydrogels to all be successfully employed as receptor amplifiers within 
sensing methodologies.  
 
Polymers 
Prior to the introduction of self-immolative dendrimers, the development of conjugated polymers was fundamental to enabling 
receiver amplification as this allows communication between repeating units of the polymer.283 Functionalising the conjugated 
polymers, known as “molecular wires”, with analyte-responsive receptors generates a single compound with multiple linked 
receptors. However, it was the use of fluorescent conjugated polymers developed by Swager et al. that adapted the molecular 
wire approach to be used for receptor amplification within a sensing application (Scheme 50).284 
 In a seminal publication, Zhou and Swager described the use of cyclophane receptors attached to a polyphenylacetylene 
backbone for the fluorescent detection of paraquat (PQ) (Scheme 51).285 A strongly fluorescent molecular wire was synthesised 
through palladium-catalysed cross coupling of 4-iodophenylacetylene monomers equipped with  bis(p-phenylene)-34-crown-10 
(BPP), an excellent binder of PQ.286 In the presence of the analyte 95, PQ was shown to dramatically quench the fluorescence of 
the conjugated polymer in comparison to the monomer. In fact, a 65-fold increase in quenching was observed through the 
Figure 5 Concept of receiver amplification and the structures of dendrimers 92, 93 and 94.  
Scheme 50 The molecular wire approach to receptor amplification. 
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molecular wire approach, which was attributed to energy 
migration transmitted throughout the polymer. In other 
words, a single analyte binding to a single receptor is able to 
exhort fluorescence quenching over the entire polymer. At 
high molecular weight polymers though, a marked decrease 
in sensitivity is observed due to the length of the polymer 
being longer than the diffusion length of excitation. Attempts 
to increase the diffusion length of excitation by enhancing the 
delocalisation throughout the polymer backbone in order to 
improve sensitivity were unsuccessful.287 Increased 
sensitivity can be achieved however through deposition of 
the molecular wires into thin films as energy migration can 
then occur between individual polymers.288 
 The concept of receiver amplification employed by this 
method has allowed amplification to be applied to the large 
array of simple analyte receptor systems previously 
developed, enabling lower LODs to be obtained through 
these conjugated polymer-based chemical sensors.289 The 
considerable number of polymerisation techniques, as well as 
the number of analyte receptors available, has meant that 
the amplified detection of small ions, explosives and 
biomolecules can be achieved using fluorescent conjugated 
polymers.290 Not only this, but modification of the polymer 
backbone has allowed for colorimetric derivatives of 
receiver-amplified polymer-based detection methods to 
become possible allowing analyte detection to be achieved 
with the unaided eye.291 
 Typically, conjugated polymers display fluorescence and it 
is in the presence of the analyte that fluorescence is 
quenched. In contrast, Leclerc et al. demonstrated the use of 
conjugated-polymers for signal-amplified switch-on 
fluorescent nucleic acid detection (Scheme 52).292 In this 
invention, a cationic, water soluble, thiophene-derived 
conjugated polymer,293 and an anionic, complementary 
strand of probe DNA initially come together through electrostatic interactions. The complexes then aggregate together because 
of their poor solubility in aqueous media and due to the close proximity of the polymers, as well as polymer stiffening, fluorescence 
quenching is observed.294 In the presence of target 
DNA, hybridisation preferentially occurs with the 
probe DNA and a stable triplex is formed where the 
conjugated polymer is wrapped around the DNA 
double helix, bound to the anionic phosphate 
backbone. The resulting uniform, helical structure 
of the conjugated polymer, along with the triplex 
being more soluble in water, leads to dequenching 
and a switch on of fluorescence. This technique was 
shown to be surprisingly selective as well as 
sensitive since a two base pair mismatch can be 
easily discriminated and a LOD of 2.4 aM after an 
assay time of 1 hour can be achieved. Labelling the 
probe DNA with a fluorophore whose optimal 
absorption wavelength is identical to the emission 
wavelength of the conjugated polymer can provide 
FRET enhancement within the detection 
methodology.295 This not only improves selectively 
since a single base pair mismatch could be 
distinguished, but also improves sensitivity as a LOD 
corresponding to 3 zM could be achieved after just 
Scheme 51 The molecular wire approach for the fluorescence detection of PQ. 
Scheme 52 Conjugated polymers for fluorescence detection of nucleic acids.  
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a 5 minute assay time. This increase in 
sensitivity is attributed to additional 
fluorescence signal amplification (FSA),296 as 
one conjugated polymer is capable of 
exciting a large number of fluorophores.297  
 The ability to transform stimuli-responsive 
polymers into smart surfaces capable of 
delivering inherent analyte detection and 
response amplification simultaneously has 
been an attractive research goal with a 
number of potential applications.298 As such, 
Phillips et al. have recently been in the 
process of developing stimuli-responsive 
polymeric materials capable of converting 
localised signals into global macroscopic 
responses.299 In order to achieve an 
application within sensing, these polymeric 
materials were then coupled with a signal 
producing mechanism enabling a local 
molecular detection event to be translated into a macroscopic fluorescent response (Scheme 53).300 To achieve this, a non-
fluorescent polymeric film was first synthesised armed with analyte-responsive triggers specifically designed for thiol detection. In 
the presence of the target analyte, in this case L-cysteine 96, selective deprotection of the nosyl groups occurs revealing a phenol 
capable of undergoing an intramolecular cyclisation reaction to generate a fluorescent coumarin moiety.301 In the same instance, 
an equivalent of ethanethiol is also released and is able to react with neighbouring nosyl protecting groups upon the polymer, thus 
propagating the signal and amplifying the response. A non-fluorescent film covering 500 mm2 was transformed to complete 
fluorescence in response to a 0.1 mM concentration of cysteine after 48 hours. Despite the long assay time required to achieve 
full conversion at low analyte concentrations, minimal background reactions in the absence of the target were also observed 
demonstrating sufficient material stability. 
 
Encapsulated Reagents 
The concept of encapsulation to segregate 
reaction reagents and slowly release them in 
response to product formation for reaction 
rate acceleration is a well-known method of 
providing chemical amplification.302–303 
Manipulating this premise towards a sensing 
methodology requires modification of the 
capsule to release its contents selectively in 
the presence of the analyte and a change in 
physical property must accompany content 
release in order for effective analyte 
detection.  
The discovery of fluorophores that 
undergo self-quenching at high 
concentrations,304 such as fluorescein,305 has 
enabled the development of ‘switch-on’ 
fluorescent sensing methodologies utilising 
polymeric assemblies and supramolecular 
structures that display stimuli-responsive 
fluorescence emission characteristics.306 In a 
prime example of this, Matile et al. described 
the use of synthetic supramolecular pores 
within vesicles for the fluorescent detection 
of enzyme activity (Scheme 54).307 Artificial 
rigid-rod molecules capable of self-
assembling into β-barrels,308 were 
Scheme 53 Stimuli-responsive polymeric films for fluorescence thiol detection. 
Scheme 54 Fluorometric detection of enzyme activity with synthetic supramolecular pores.  
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constructed and then filled with anionic enzyme substrate adenosine triphosphate (ATP) 99, which can bind to the cationic inner 
wall of the barrel through electrostatic interactions. The blocked barrels were then slipped into the lipid bilayer of a vesicle 
containing a high concentration of 5-
carboxyfluorescein 98 and as such, were non-
fluorescent. Since a large number of synthetic 
pores, or analyte receptors, are present per 
vesicle and only one is needed to be unblocked 
to release its cargo then significant receptor 
amplification is demonstrated by this 
approach. In the presence of the analyte, a 
nonspecific adenosine triphosphatase 
(ATPase) enzyme,309 dephosphorylation of 
ATP 99 to adenosine monophatase (AMP) 100 
occurs. Due to the decrease in size and the 
reduced number of anionic binding sites, AMP 
is unable to sufficiently block the barrel and is 
expelled. Once the barrel is unblocked, this 
allows the release of the trapped molecules 
within the vesicle through the synthetic pores 
and into the reaction medium. Consequently, 
dilution of 5-carboxyfluorescein 98 prevents 
self-quenching leading to the observed turn-
on of fluorescence.  
 The versatility of this amplification 
methodology was also shown as it was easily 
adapted to the detection of other enzymes, 
such as aldolases and phosphatases, through the use of the appropriate unmodified enzyme substrates as pore blockers. However, 
the advantage of not requiring labelled enzyme substrates is highly dependent on the enzyme substrate showing high affinity for 
the pores and the enzyme product having a significantly lower affinity. In particular, to enable vesicle receptor amplification for 
the fluorescent detection of ATP, an analyte detection method without synthetic pores had to be used.310 Despite this, the rigid-
rod approach for the development of synthetic, multifunctional pores capable of responding to changes in pH, concentration and 
voltage,311 has enabled a variety of different analytes to be detected using synthetic and bioengineered membranes.312 
 Similarly to self-quenching fluorophores, the phenomenon of molecular signal changes at high label concentrations also occurs 
with self-assembling fluorine-containing 
compounds when using 19F nuclear magnetic 
resonance (NMR) as the detection method. 
Developed by Hamachi et al., a detailed study 
was conducted into the different 
combinations of monomers that could be 
obtained through modification of the 
fluorine-containing tail group, the linker and 
the analyte-responsive head group and the 
effect this would have upon self-assembly.313 
The successful formation of spherical, self-
assembled nanoprobes, with the fluorine-
containing tail-groups on the inside, was 
determined by a switch-off of the 19F NMR 
signal. Since the outside of the nanoprobe is 
covered with the analyte-responsive head 
groups and modification or removal of just 
one could disrupt aggregate formation, then 
considerable receptor amplification can be 
achieved.  
 To adapt this observation towards a 
sensing methodology, the group used 
nitrobenzene head groups for the 19F NMR 
detection of the enzyme nitroreductase 
Scheme 55 Receptor amplification through self-assembling probes for the 19F NMR detection of 
enzyme activity. 
Scheme 56 Structure of both the size-selective gate and the hinge, and their use in the construction 
of pH-controlled, enzyme-encapsulated, mesoporous silica nanoparticles. 
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(NTR) (Scheme 55).314 In this approach, enzyme-catalysed reduction of the nitro group upon probe 101 to the corresponding aniline 
102 generates an unstable intermediate that undergoes 1,6-elimination to afford reporter molecule 103. Subsequently, 
disaggregation of the nanoprobes occurs and a switch-on of the 19F NMR signal is observed. Importantly, due to the designed 
elimination procedure, a shift in the 19F NMR signal is also observed which confirms the detection of enzyme activity via the 
proposed mechanism as opposed to nanoprobe disaggregation occurring through other means. The adaptability of this technique 
was also demonstrated as by changing the head group to a specific peptide chain, the amplified 19F NMR detection of cancer 
biomarker MMP2 could be achieved. The nanoprobes also exhibit excellent biocompatibility and this method has been 
demonstrated for both cell surface,315 and intracellular protein imaging.316 
 Stimuli-responsive release of encapsulated 
reagents,317 has enormous application to a 
number of biomedical applications such as 
drug delivery and self-healing materials.318 
As such, a considerable number of analyte-
triggered reagent release methodologies are 
not necessarily designed for sensing 
purposes.319–320 Recently, advances have 
been made from encapsulated reagents to 
encapsulated enzymes in an effort to 
provide further amplification as well as to 
achieve programmed enzymatic 
reactions.321 From a sensing perspective, 
one particular contribution of note was 
provided by Xue and Zink who demonstrated 
an enzyme chemical amplifier using 
mechanised nanoparticles.322 
 In this method, size-selective pH-controlled 
silica nanoparticles were constructed 
containing porcine liver esterase (PLE) and 
capped with a star-like gate through imine 
hinges (Scheme 56).323 The gate allows the 
coexistence of the enzyme and enzyme 
substrate in the same media yet prevents 
their interaction through size-exclusion. 
System activation occurs in the presence of 
the analyte, 4-acetoxycinnamaldehyde 
(ACA) 104, which is small enough to fit 
through the gate and is subsequently 
hydrolysed by the enzyme (Scheme 57).324 
The acid produced as a result of enzyme 
hydrolysis is then capable of catalysing the 
hydrolysis of the imine hinges holding the 
gate in place. Once all the linkages are 
broken, the gate is removed from the 
nanoparticle which therefore allows 
interaction between the enzyme and pro-
fluorescent enzyme substrate, 5-
carboxyfluorescein diacetate (CFDA) 103. 
Enzyme-catalysed hydrolysis of enzyme 
substrate CFDA not only allows enzyme activity to be measured by fluorescence but also produces further equivalents of acid, 
which leads to further gate removal and therefore an increased rate of fluorescence production. Although the system 
demonstrated autoinductive amplification, reaction times were long owing to the slow turnover rate of the enzyme. Also, this 
methodology is limited to the detection of acylated compounds that are small enough to fit through the gaps in the gate. Despite 
this, background rates are negligible showing that enzyme activity can be effectively controlled using size-selectivity and this 
methodology could have wider application within biosensing due to both the high biofunctionality and biocompatibility of 
mesoporous silica nanoparticles.325 
 
Scheme 57 Size-selective, pH-controlled, enzyme-encapsulated mesoporous silica nanoparticles for 
the fluorescence detection of small, acylated compounds. 
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Hydrogels 
Hydrogels are hydrophilic polymer 
networks that can absorb up to 99% of their 
own weight in water without dissolution.326 
They possess the ability to contain a large 
number of analyte receptors either 
physically encased within the polymer 
matrix or covalently bound to the polymer 
and can induce a considerable physical 
response in the presence of specific 
stimuli.327 This, along with their high 
biocompatibility,328 has seen the inclusion 
of hydrogels within a number of sensing 
applications such as temperature and pH 
monitoring,329 as well as for the detection 
of biologically-related material.330 Typically, 
the physical response elicited is either 
through swelling or shrinkage of the 
hydrogel and this response can be 
measured through changes in optical 
transmission,331 or refractive index.332 
However, these methods require 
sophisticated instrumentation to afford an 
accurate readout and as a result, there has 
been efforts made to induce complete 
disintegration of the hydrogel in response 
to an analyte allowing for naked eye 
detection. Furthermore, by accompanying 
full dissolution of the hydrogel with a colour 
change, then an unambiguous positive result 
can be easily determined by eye. One such methodology was developed by Tan et al., who developed an aptamer-based 
colourimetric hydrogel platform for the visual detection of cocaine 88 (Scheme 58).333  
In this procedure, amylase enzyme amplifiers were trapped within a cross-linked polymer hydrogel that was dependent on 
DNA aptamers, that are selective for cocaine 106, for structural support.334 In the presence of the analyte, competitive binding for 
the aptamers occur leading to hydrogel destabilisation and then inevitable dissolution of the hydrogel with concomitant release 
of amylase enzymes. Thus, the enzyme-catalysed breakdown of amylose is initiated and when the assay medium is stained with 
iodine, the characteristic blue colour associated by the presence of amylose does not appear.335 The combined receiver 
amplification of the hydrogel and the signal amplification delivered by the enzyme enabled cocaine detection to less than 20 ng 
with the naked eye within 10 minutes. Due to the use of DNA aptamers for analyte detection high selectivity for cocaine over 
structurally similar compounds such as benzoylecgonine (BE) and ecgonine methyl ester (EME) was also observed. Enzyme 
trapping, compared with some enzyme conjugation methods, is extremely mild yet effective as no loss of enzyme activity was seen 
between trapping and activation. Also, no undesired substrate breakdown was seen in the absence of the analyte since the 
hydrogel and the enzyme substrate are both polymers. As glucose 107 is produced as a result of the enzyme-catalysed breakdown 
of amylose, cocaine detection can also be measured quantitatively with a commercially available personal glucose meter.336 
Supramolecular hydrogels, hydrogels constructed solely on the self-assembly of small molecule hydrogelators rather than 
through chemical cross-linking or polymerisation, are becoming increasingly popular because in addition to being able to support 
biomaterial within the hydrophilic gel, hydrophobic molecules such as fluorophores can also be supported within the 
supramolecular framework itself.337 As such, a considerable number of supramolecular hydrogels have been used for a number of 
fluorescent chemosensors that respond to molecular recognition and enzyme activity.338 Of particular note are the supramolecular 
hydrogel-based sensing techniques developed by Hamachi et al. that have been shown to be easily adaptable towards the 
fluorescent detection of polyanions,339 polycations,340 and PSA.341 However, continuing the endeavour for analyte detection 
without instrumentation, the group very recently successfully coupled their chemically reactive supramolecular hydrogel with a 
DCR-type amplification procedure for the naked-eye detection of uric acid in human plasma (Scheme 59).342 
In this protocol, supramolecular hydrogels designed to be selective towards hydrogen peroxide, were constructed containing 
three components; analyte selective enzyme urate oxidase (UOx), signal transducing self-immolative compound 110, and signal 
amplifying enzyme sarcosine oxidase (SOx). Despite the high number of encapsulated reagents, the hydrogels were shown to be 
Scheme 58 An aptamer-bound, enzyme-encapsulated hydrogel for colourimetric cocaine detection. 
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physically stable. In the presence of uric acid 
108, a biomarker for gout,343 UOx catalyses its 
oxidation to 5-hydroxyisourate 109 producing 
hydrogen peroxide as a byproduct, which can go 
on to oxidise signal transducing reagent 110 to 
its corresponding phenolate 111. This 
intermediate is unstable under the assay 
conditions and eliminates to produce two 
equivalents of sarcosine 112. Signal amplifying 
enzyme SOx then catalyses the oxidative 
demethylation of sarcosine 112 to glycine 113 
producing more molecules of hydrogen peroxide 
in the process. This can go on to react with more 
equivalents of 110 or react with phenylboronic 
acid residues upon the hydrogel framework. 
Oxidation and subsequent elimination of these 
residues is enough to destabilise the matrix and 
cause collapse of the hydrogel, a physical effect 
visible by eye. This system was capable of 
detecting 80 μgmL−1, the threshold level of 
hyperuricemia, with the naked eye following a 3 
hour incubation. The sensitivity was attributed 
to the amplification provided by DCR, allowing 
for a 5-fold decrease in analyte concentration 
that could be detected via this method. In 
addition, by swapping SOx with GOx, the 
detection method was easily adapted towards 
the detection of glucose. This mix-and-match 
approach using different enzymes allows the 
system to provide logic-gate output responses 
from different biological substance input 
signals.344  
Conversely, signal production can also be 
attributed to hydrogel formation, rather than 
hydrogel dissolution, as Liang et al. recently 
demonstrated.345 In this method, a tetrapeptide 
substrate for ALP was synthesised comprising of 
a phosphorylated tyrosine residue for target 
recognition and a fluorescein moiety to enable 
orthogonal enzyme detection to be achieved via 
fluorescence. In the absence of the enzyme, a transparent yellow solution is apparent and exhibits strong green fluorescence 
emission under UV irradiation. Dephosphorylation of the substrate was shown to occur selectively only in the presence of ALP and 
the hydrogelator product, once obtained in high conversion, self-assembles into nanofibres to form a hydrogel. In addition to the 
physical change of the assay, aggregation-induced quenching (AIQ) is also observed leading to a decrease in fluorescence. The 
assay exhibited a good dynamic range, obtained a LOD of 0.06 UmL−1 and could be used to quantitatively measure ALP activity 
within living cells. 
Conclusions 
Molecular amplification for sensing applications can now be achieved through a considerable variety of different approaches; 
whether focussed on target, label, signal or receptor amplification. The selection of which amplification strategy to choose is not 
necessarily a case of which one provides the greatest amplification but more a matter of which one is most suitable as part of a 
particular detection assay. This is dependent on the analyte being detected, the medium the analyte is being detected from, the 
medium the amplification is taking place in and the desired readout signal. Factors such as the required selectivity and sensitivity, 
as well as time and cost, also play an important role in selecting the most suitable amplification method. 
 Analyte detection methods are constantly evolving. Reversible affinity-based analyte recognition has made way to irreversible 
reaction-based analyte recognition in order to improve sensitivity. In addition; simple indicator-based approaches to sensing are 
Scheme 59 DCR-enhanced, chemically-reactive supramolecular hydrogel for the visual 
detection of uric acid. 
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now being made obsolete by easy-to-perform, amplified detection assays. Recently, single-amplifier techniques have been 
elaborated with multiple amplifiers in a bid to achieve even greater sensitivity. Current efforts are being made not only towards 
the inclusion of multiple amplifiers but also the incorporation of multiple amplification approaches, such as target and signal 
amplification within the same detection assay. However, the strive to obtain lower and lower detection limits by more and more 
powerful amplification methods can lead to over-complication and problems with false-positive results from accidental activation. 
This is particularly true with regards to the attractive exponential amplification displayed by autocatalytic methods. Therefore, the 
ability to maintain low background signals as well as analyte selectivity is becoming increasingly important and not just sensitivity. 
 Future amplification methodologies will always aim for a detection limit of a single molecule within a complex mixture with 
the naked eye. This is not the only goal within sensing however as complex diseases, such as cancer, require the successful 
detection of a panel of biomarkers prior to diagnosis, not just one. Therefore, the ability for amplification methodologies to 
demonstrate multiplexed detection without interference is highly desirable. General reagent-based amplification strategies are 
also in high demand as the ability to choose an appropriate reagent for a specific analyte with a particular readout where 
amplification is guaranteed will prove to be very adventitious within clinical diagnosis. Previously, it has been highlighted that the 
best results are obtained in systems that rely on cascades of amplification events and that most amplification protocols rely on 
hybrid systems. Current objectives within sensing should therefore be to develop amplification cascades that utilise both biological 
and synthetic components to utilise selectivity, sensitivity and versatility within analyte detection assays. 
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